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ABSTRACT 
The chromatic contribution to brightness perception was compared in males and 
females.  Direct brightness matching (DBM) and heterochromatic flicker photometry 
(HFP) were used to measure relative luminous efficiency, and DBM/HFP ratios were 
predicted to be higher for females than males on repeated measures and for each 
“primary” color.  No gender differences were predicted in DBM or HFP measures.  
Within-females effects of estradiol (E2) and progesterone (PG) levels, contraceptive use, 
and menstrual cycle phase were also investigated.  It was expected that E2 would directly 
predict DBM/HFP ratios and that PG would antagonize that relationship.  Based on that 
prediction, DBM/HFP ratios would be at a maximum during the ovulatory phase, 
intermediate during the menstrual phase and minimum during the luteal phase.  No 
effects were predicted for DBM or HFP measures. 
DBM/HFP ratios were significantly higher for female subjects than male subjects. 
Contraceptive use had no effect on overall DBM/HFP ratios.  There were limited effects 
of hormone levels, menstrual cycle phase and contraceptive use on DBM/HFP ratios and 
on DBM and HFP measures analyzed separately.  However, hormone effects on 
DBM/HFP ratios and DBM measures at 650 nm agree with previous findings involving 
long-wavelength sensitive (L-) cone mechanisms.  
The present findings supporting a female advantage in chromatic contribution to 
brightness are robust.  The significant results are discussed in the context of previous 
findings suggesting organizational and short-term effects of ovarian steroid hormones. 
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INTRODUCTION 
PROPERTIES OF LIGHT 
 Humans are capable of detecting electromagnetic radiation from 380 to 700 
nanometers (nm).  This visible radiation, or light, has two basic properties—luminance 
and chromaticity.  Luminance, or lightness, is transformed by the visual system and is 
perceived as brightness.  Chromaticity likewise undergoes a transformation and is 
perceived as color, which has two properties—hue and saturation.  Hue defines where a 
light stimulus falls on the visual spectrum and can be thought of as the name we give a 
color (blue, red, orange, etc.)  Saturation is a more difficult concept and has been defined 
as “the attribute of a visual sensation which permits a judgment to be made of the degree 
to which a chromatic stimulus differs from an achromatic stimulus regardless of their 
brightness” (Wyszecki and Stiles, 1982).  A simpler approach is to say that highly 
saturated stimuli contain more color and pale colors contain more white (Pokorny et al., 
1991).  Hue then tells us the color of an object, and saturation tells us how colorful the 
object is.   
 
ANATOMY AND FUNCTIONAL MODELS OF THE VISUAL SYSTEM 
Parallel visual pathways 
There are numerous processes involved in transforming visual sensations into the 
perception of brightness and color.  In humans and other primates, physiological and 
behavioral evidence indicate two anatomically and functionally distinct pathways 
originating in the magnocellular (M) and parvocellular (P) retinal ganglion cells 
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(Leventhal et al., 1981; Perry et al., 1984).  Object location, movement, low contrast 
sensitivity and global analysis of visual scenes are processed more efficiently through the 
M-cell pathway, whereas object and pattern recognition as well as color (in particular, 
red-green opponency) are processed more efficiently through the P-pathway (Schiller and 
Malpeli, 1978; Livingstone and Hubel, 1987; De Yoe and Van Essen, 1988; Brannan and 
Bodis-Wollner, 1991; Plainis and Murray, 2005).  The M and P retinal ganglion cells 
project to the dorsal portion of the lateral geniculate nucleus (dLGN) of the thalamus, and 
the dLGN projects to cortical areas involved in visual processing, chiefly to primary 
visual cortex (V1).  These M and P pathways can be followed deep into visual processing 
areas of posterior parietal (PP) and inferior temporal (IT) cortex and are thought by some 
to form anatomically distinct dorsal (M) and ventral (P) processing streams (Mishkin and 
Ungerleider, 1982).  A third functional system, the koniocellular (K) pathway, involves a 
neurochemically distinct population of neurons in the interlaminar zones of the dLGN 
(Casagrande, 1994).  Though these K cells are more variable in size and function, they 
have the lowest spatial acuity and intermediate temporal resolution when compared to M 
and P cells.  A subset of K cells relay low-acuity visual information to V1, while others 
innervate cortical areas outside of visual cortex likely to augment visual behaviors in the 
absence of normal V1 function (Hendry and Yoshioka, 1994).   
There is general agreement concerning the existence and clinical relevance of 
these parallel pathways (reviewed by Bassi and Lehmkuhle, 1990).  The persistent debate 
is whether individual differences in parallel pathways lead to measurable differences in 
visual processing.  Since my research intimately involves the debated mechanisms, a 
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summary follows of major findings in retinal anatomy, physiology and models of visual 
sensation and perception. 
 
Retinal anatomy and physiology 
 There are three major types of neurons in the retina—photoreceptors, bipolar cells 
and ganglion cells.  The light gathering elements (photoreceptors) in the vertebrate retina 
are long, tubular neural cells whose names describe the shape of their free ends—rods 
and cones.  It is generally accepted that there is one type of rod and three types of cones 
in normal human retina (Dowling, 1987).  Cone types are categorized based on their peak 
sensitivity to long (L-cone), medium (M-cone) or short (S-cone) wavelengths (Cohen, 
1992).  Rods are primarily responsible for visual detection in dim light, while cones are 
more adapted for the sensation of form and color in higher light levels.  While there are 
individual differences, the number of rods in the human retina is estimated at 120 million, 
and cones number 6.5 million (Snell and Lemp, 1989).  The density of photoreceptors 
varies in different parts of the retina.  The foveal region of the retina—important for fine 
central vision tasks such as driving and reading—contains no rods, while the density of 
rods is about 30,000/mm2 in the far peripheral retina.  The opposite is true for cones, 
which are much denser in the fovea and decrease in number in the periphery.  The fovea, 
however, contains almost no S-cones.  This probably indicates the secondary role of S-
cones in fine spatial vision (Cohen, 1992). 
 In his review of retinal contributions to color pathways, Lee (2004) provided the 
following view of retinal organization.  Bipolar cells connect photoreceptors with 
 
Foutch, Brian, 2007, UMSL, p. 5 
ganglion cells, the axons of which form the nerve layer carrying initial visual 
transformations to the dLGN.  Rod bipolar cells synapse with several rods and up to four 
ganglion cells called parasol cells.  Diffuse bipolar cells connect several L and M cone 
cells to parasol cells, which project to the magnocellular layers of dLGN.  Parasol 
ganglion cells have large cell bodies that are tuned for low spatial and high temporal 
frequency.  Midget bipolar cells (which can be inhibitory or excitatory) connect 
individual L or M cones to individual midget ganglion cells in the ganglion layer.  This 
arrangement is thought to be responsible for fine spatial resolution and red-green (L-M) 
color comparisons of the P pathway.  A final type of bipolar cell, the bistratified bipolar 
cell, connects S cones to bistratified ganglion cells.  Bistratified cells also receive an 
inhibitory input from L and M cones (through diffuse bipolar cells) and result in the 
ability of the visual system to make +S-(M+L) or blue-yellow comparisons.  A subset of 
these bistratified cells is thought to form the basis for the koniocellular neural pathway 
(reviewed by Lee, 2004).   
 In addition to serial connections, there is a parallel arrangement in the primate 
retina facilitated by horizontal and amacrine cells.  As predicted from their name, 
horizontal cells project laterally in the retina and connect distant photoreceptors to one 
another and with bipolar cells.  In mammals, there are two horizontal cell types (H1 and 
H2).  In primates, H1 cells avoid S cones, while H2 cells make substantial connections to 
S cones and to L and M cones.  Horizontal cells integrate the visual signal by responding 
to neurotransmitter released from rods and cones, sending an inhibitory signal to bipolar 
cells.  Horizontal cells are also thought to be involved in cone-specific or local gain-
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control in the outer retina (Lee, 2004).  Amacrine cells synapse with ganglion cells and 
bipolar cells as well as with one another.  They are stimulated by bipolar cells and 
provide excitatory input to ganglion cells. 
 Even at the retinal level of visual transformation, one can see the genesis of two 
basic aspects of visual sensation—color and brightness.  These are not completely 
independent functional systems, as the M- and P-pathways interact (Milner and Goodale, 
1995).  That is, the M-pathway is not entirely achromatic and the P-pathway is not the 
sole processing system for chromatic information.  After all, the M-pathway does contain 
information from wavelength coded sensors and contributes to color even at relatively 
low light levels (Lee, 1999).  In addition, the interactions of rods with all cone types via 
lateral connections involve the P-pathway in visual transformations at all perceivable 
intensity and contrast levels (Lee, 1999; Buck et al., 2000).  However, the P-pathway, 
tuned primarily for high spatial frequency and color information, provides limited 
information about the overall form of objects (Livingstone and Hubel, 1987).  In fact, it is 
nearly impossible to discriminate between forms in natural scenes without activation of 
contrast mechanisms of the M-pathway.  Therefore, careful stimulus and experimental 
design can be used to largely isolate magnocellular, parvocellular and even koniocellular 
function. 
 
Models of color sensation and perception 
Although the concept that white light is composed of separate colors was 
discovered as early as 100 AD, Sir Isaac Newton is usually credited with being the first to 
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analyze the color spectrum of light in terms of vision (Gouras, 1991).  That is, he 
recognized that objects would take on the color of light they reflected the most and 
concluded that light was capable of stimulating the retina to produce colors (Newton, 
1671).  Although his theories on color mixing have endured, even evolving into the 
current science of colorimetry, Newton was not able to understand that the retina—not 
the light itself— is the limiting aspect in color mixing.   
Almost a century later, Palmer reasoned that the three primary pigments used in 
art and textiles had three matching receptors in the retina (Gouras, 1991).  Palmer’s 
theories were groundbreaking.  He understood that color deficiency would result from 
missing receptor types.  He also recognized that receptors with peak sensitivity to a 
particular pigment would respond to other pigments if intense enough.  Having been 
exposed to Palmer’s work, Thomas Young proposed in his second Bakerian lecture that 
the human visual system contained three nerve fiber types, each producing a red, green or 
violet sensation.  
Now, as it is almost impossible to conceive each sensitive point of the retina to 
contain an infinite number of particles, each capable of vibrating in perfect unison 
with every possible undulation, it becomes necessary to suppose the number limited, 
for instance, to the three principal colours, red, yellow, and blue, of which the 
undulations are related in magnitude nearly as the numbers 8, 7, and 6; and that each 
of the particles is capable of being put in motion less or more forcibley by 
undulations differing less or more from a perfect unison; for instance the undulations 
of green light being nearly in the ratio of 6 ½ will affect equally the particles in 
unison with yellow and blue, and produce the same effect as a light composed of 
these two species: and each sensitive filament of the nerve may consist of three 
portions, one for each principal colour. – Young (1802: pp. 20-21) 
 
Foutch, Brian, 2007, UMSL, p. 8 
While advancing his wave theory of light as vibrations in luminous elastic ether, 
Young observed, “The sensation of different Colours depends on the different frequency 
of Vibrations, excited by Light in the Retina.”  He also suggested that the retina might be 
sensitive to only three principal colors and that all color appearance, including blacks and 
whites, might be attributable to varying degrees of excitation of these three receptors.   
The psychophysical studies of Helmholtz (1852) also suggested three receptor 
types that respond at different rates depending on the wavelength of incoming light rays. 
The Young-Helmholtz theory, which argued that the visual system is able to derive all 
color perception (including overall lightness) from three types of photoreceptors, has 
been repeatedly supported by modern studies.  For example, Marks et al. (1964) as well 
as Sperling and Harwerth (1971) used microspectrophotometric techniques to verify the 
existence of three photoreceptor types with peak sensitivities to low, medium and long 
wavelength light.  So, at the level of photoreceptors, a strong relationship emerges 
between the wavelength of light and the neural signals. 
Regardless of how prescient the Young-Helmholtz trichromatic theory was in 
predicting three wavelength-dependent photoreceptors, it could not completely describe 
color perception.  Ewald Hering, the father of the opponent process theory, made some 
very interesting observations that could not be accounted for by the trichromatic theory 
(Hurvich and Jameson, 1964).  For example, he noted that there are certain pairs of 
complementary colors one never sees together at the same place and at the same time. For 
example, while humans can perceive yellowish-greens or bluish-reds, it is impossible to 
perceive reddish-greens or yellowish-blues.  Hering hypothesized an opponent process 
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that caused red and green, as well as blue and yellow, to cancel each other.  Hering also 
observed that there was a distinct pattern to the color of perceived afterimages.  That is, if 
one looks at a certain color for about a minute and then switches the gaze to a 
homogeneous white field, a patch of complementary (or opponent) color will appear. 
Another problem for the trichromatic theory is in the nature of the human 
subjective response of yellow hues.  Trichomatic theory predicts three primary colors—
blue, green and red—with none appearing to be a combination of the other two.  This 
agrees with our subjective experience.  After all, blue is not a combination of green and 
red and so on.  Trichromatic theory also predicts that non-primary colors are 
combinations of primary colors.  Cyan is the combination of blue and green, and purple is 
the combination of blue and red.  These also agree with our subjective experience.  
However, yellow—physically resulting from the combination of green and red—does not 
make sense in the same way. 
Hering hypothesized that trichromatic signals from the cones fed into subsequent 
neural or post-retinal stages and allowed for two major opponent classes of processing.  
The first process—the substrate of color sensation—was the spectrally opponent process 
involving red vs. green and blue vs. yellow.  He also hypothesized a second spectrally 
non-opponent (black vs. white) process resulting in brightness sensation. This opponent 
process model lay relatively dormant for many years until two vision scientists at 
Eastman Kodak, Leo Hurvich and Dorothea Jameson, conceived and engineered the hue 
cancellation method to psychophysically evaluate opponent processing in color vision 
(Hurvich and Jameson, 1957).   
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It was predicted from opponent process theory that red and green should not mix 
to form reddish-green.  Rather, red and green cancel each other, and the addition forms 
yellow.  Blue and yellow also do not mix.  They cancel each other, and the addition forms 
white.  Hurvich and Jameson then reasoned that if one started with a bluish-red color, it 
should be possible to add unique green (green containing minimal influence of other 
hues) to cancel out the redness, leaving only blue.  Unique green was also used to cancel 
out the redness in orange, leaving only yellow.  For yellow-green stimuli, unique blue 
was used to cancel out the yellow, leaving only green.  The amount of the cancellation 
color used was taken as the strength of the cancelled hue.  These data were then 
converted to produce red-green and blue-yellow opponent process curves as shown in 
Figure 1 (adapted from Hurvich and Jameson, 1957). 
Opponent Process Curves
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Figure 1 – Opponent process curves for a single observer (adapted from Hurvich and 
Jameson, 1957).  The arrows indicate the wavelength positions of unique blue, green and 
yellow for this observer.  The sign (plus or minus) of the chromatic response is arbitrary 
and represents the opposite nature of the opponent processes. 
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It may seem at first that trichromatic and color-opponent theories are 
incompatible.  However, modern dual process (or zone) theories view the models 
together with the three cone classes combined in an antagonistic fashion at the post-
receptor level (Boynton, 1979).  The dual process theory, which is currently the accepted 
model of color processing, also proposes a non-color opponent class of neurons 
(DeValois et al., 1966).  The spectral sensitivity function of these neurons is broad with a 
peak around 555 nm, which has led some to conclude that their activity is due to the 
combined activation of M- and L-cone mechanisms.  Some authors even credit these non-
opponent neurons with the shape of photopic spectral sensitivity functions (Cavanagh et 
al., 1987).  Analogous to this suggestion is the idea that S-cone mechanisms are “color 
only” (Cavanagh et al., 1987), although this is a minority opinion.  Individual differences 
in post-receptoral retinal or ganglion cell organization may also result in M+L (yellow) 
perception differences.  Therefore,  it is easy to imagine that individual differences in the 
number of cone photoreceptors would alter achromatic and chromatic processes across all 
wavelengths.  
Previous studies have suggested that individual differences in color perception 
may result from gender, and several of these studies are discussed in the following 
section. 
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GENDER DIFFERENCES 
General gender differences 
Physical gender differences exist early in fetal development and are the result of a 
series of prenatal hormone processes that may also produce gender differences in neural 
development (Levine and Mullins, 1966). There are also known sex differences in 
cortical (Luders et al., 2004) and subcortical (Shors et al., 2001) structures which may 
contribute to gender-specific cognitive or memory function.  In addition, there are gender 
differences in the incidence of certain illnesses (Kudielka and Kirschbaum, 2005).  
Women, for example, suffer more often from autoimmune disorders while men are more 
likely to contract infectious diseases or develop cardiovascular disease earlier in life.  
Functional differences may also result from different experiences and expectations 
(Slonim et al., 1975; Hamilton, 1995).  There is also some experimental evidence of 
structural and functional differences in visual processing between the sexes (reviewed by 
Alexander, 2003).   
 
Gender differences in ocular anatomy and visual processing 
Although the results of previous gender studies of visual processing are 
heterogeneous, they suggest sexual dimorphism in visual structure and function that may 
extend to color processing.  Some reviewers have concluded that women differ from men 
in ocular features such as tear production, lens clarity, and corneal shape and thickness 
(Midelfart, 1996).  Zadnick et al. (2003) found that girls had more powerful corneas and 
lenses but shallower anterior chambers than boys.  Others have found, however, no 
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gender differences in the anatomy of the eye (reviewed by Jones, 1990).  In squirrel 
monkeys, Jacobs (1983b) described sex differences in spectral responses of LGN cells.  
Male monkeys had a significantly smaller proportion (14%) of spectrally opponent cells 
than females (21%).   
Human sex differences in visual function and associated behaviors also have been 
reported (reviewed by Alexander, 2003).  In free drawings, boys tend to describe more 
motion and include more mechanical descriptions of imagined environmental scenes 
while girls tend to use more color (Iijima et al., 2001).  In a study designed to determine 
the effects of gender and age on dynamic visual acuity, Ishigaki and Miyao (1994) found 
that boys tended to detect a small gap at faster drifting rates than girls.  Kramer et al. 
(1996) found that, in describing large shapes made up of smaller geometrical elements, 
boys use more global descriptions (relying on the overall shape).  Girls, however, are 
more detailed (or local) in their descriptions, referring to the smaller shapes to describe 
the figures.  Of course, these differences may result from early association by boys and 
girls to “gender expected” behaviors.  For example, Hamilton (1995) found that the most 
significant predictor of visual-spatial performance was not gender but self-perceived 
masculinity.  Still, the overall body of evidence suggests possible innate gender 
differences in parallel visual processes.  That is, males may rely more on magnocellular 
processing, while females may rely more on parvocellular processing. 
As part of a study designed to compare the contrast response of the dominant eye 
to stimuli processed more strongly by magnocellular and parvocellular pathways, Foutch 
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and Bassi (2005) found a significant interaction (p = 0.025) of stimulus type (magno vs. 
parvo) with gender.  The magno stimuli were large (4° by 6°), low spatial frequency  
(1 cycle per degree), quickly drifting (30 cycles/sec) rectangular blue/yellow gratings 
while parvo stimuli were small (2°), high spatial frequency (20 cycles per degree), 
stationary circular red/green gratings.  There was also a simple effect of gender on 
contrast thresholds for the stimuli more strongly processed by the parvocellular pathway.  
Females were more sensitive than males (p = 0.05) to the high spatial frequency, red-
green stimulus, but there was no simple effect of gender on contrast thresholds for the 
magno stimuli (Figure 2).  There were also gender-related trends in reaction times 
(reported separately by Foutch and Fletcher, 2006).  Female subjects were slower than 
male subjects in reacting to magno stimuli but faster than males in reacting to parvo 
stimuli. 
 
 Mean Contrast Sensitivity 
Stimulus Type 
ParvoMagno 
1250 
1000 
750 
500 
250 
100 
0 
 
0 
1 
 10 
 50 
100 
300 
Stim
o 
ulus Type 
Parvo Magn
}  Significant difference (p = 0.05) 
Error bars: 95.00% CI 
Male 
Female 
 
Figure 2 – Contrast sensitivity results from Foutch and Bassi (2005).   
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The contrast and reaction time findings may have resulted from differences in 
either spectral sensitivity or in sensitivity to the spatial and temporal characteristics of the 
targets.  In a study designed to test visual acuity as a function of hue (blue, green, yellow 
and red), Kelton et al. (1978) found an interaction effect of gender with hue on visual 
acuities.  Therefore, it is possible that differences in spatial frequency processing account 
for gender differences in contrast thresholds of chromatic grating stimuli. 
The results are mixed in studies that carefully consider the influence of gender on 
spatial frequency processing.  Oen et al. (1994) investigated the effects of race, gender 
and occupation on spatial contrast thresholds and found that females had lower contrast 
sensitivity than males at all spatial frequencies, suggesting a male advantage in 
magnocellular processing.  However, the results of a subsequent study specifically 
designed to investigate gender differences in spatial frequency indicated no gender 
differences in contrast thresholds between 20 males and 20 females (Solberg and Brown, 
2002).  Zaroff et al. (2003) also found no significant gender differences in stereoacuity 
thresholds.  The equivocal nature of reported gender differences in spatial processing 
suggests that gender differences in parvocellular processing may result from color 
processes. 
 
Gender differences in color vision 
 The majority of investigations into gender differences in color vision deal with 
preferences and naming.  In a study of 1279 university students, Walton et al. (1933) 
found that men preferred orange over yellow, whereas the opposite was found for 
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women.  St. George (1938) and Eysenck (1941) verified these results in separate college 
populations.  In a modern study involving naming of color chips, women identified 
significantly more colors than men yet had no significant difference in vocabulary 
(Greene and Gynther, 1995).  
Several studies also have investigated directly the perceptual aspects—lightness, 
hue and saturation—of color transformations.  In an attempt to measure saturation 
sensitivity, Nichols (1885) found that males could detect smaller amounts of red, yellow, 
and green powder added to white powder while females could detect smaller amounts of 
blue powder.  His methods were flawed by modern standards as the colors were 
broadband and could have been influenced by neighboring hues.  A modern study used 
color caps from the standard Farnsworth D-15 and L’Anthony desaturated (DS-15) tests 
to investigate the possible effects of gender on lightness and saturation (Bimler et al., 
2004).  Each observer was shown a series of three small color disks, and their task was to 
eliminate the disk that did not belong.  Males eliminated color disks based on different 
lightness whereas females eliminated disks based on hue—particularly red-green—
differences.  That is, males placed more perceptual weight on lightness and less on color 
discrimination, providing more evidence for gender differences in magnocellular vs. 
parvocellular processing.  Volbrecht et al. (1997) found that the wavelength positions of a 
uniquely green hue were distributed differently for males than females.  Distributions for 
males were normal and non-skewed whereas female distributions were positively 
skewed, non-normal and bimodal.  Kuehni (2001) reported the same result for unique 
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green and similar results for the distributions of unique yellow and red.   These studies 
suggest a pattern of variability within females not observed in males. 
In order to reduce the influence of spatial frequency on the results of Foutch and 
Bassi, Foutch and Peck (2005) compared contrast thresholds between genders for 2° 
circular patches of uniform color—blue, cyan, green, yellow, orange, red and magenta—
that alternated temporally with a broadband (white) stimulus.  An alternation rate of 5 
cycles/sec was used to minimize the contribution of achromatic channels, and repeated 
measures analysis of variance (ANOVA) revealed that females had significantly higher 
thresholds for all seven stimuli (F = 10.75, p < 0.001).  Analyzing the data for planned 
(green and red) comparisons revealed significant gender differences for green (F = 10.90, 
p < 0.001) and red (F = 6.24, p = 0.014).  Even applying the conservative Bonferroni 
correction, contrast thresholds were significantly higher for females for unplanned 
comparisons of cyan, yellow, and orange.  
The higher thresholds for females did not represent lower spectral sensitivities.  
The algorithm to determine thresholds added white to the color in the first patch and kept 
the color constant in the second until the observer could no longer discriminate between 
the two when temporally alternated at 5 Hz.  Thus, the more sensitive an observer is to a 
given color, the more white that will be required to disrupt that sensation.  Therefore, a 
higher threshold on this task indicates more contribution of color to the overall sensation.  
It could be argued that these results were overly influenced by the presence of white in 
the stimuli.  In that case, the results would represent differences in saturation, rather than 
chromatic, sensitivity.  However, Graham and Hsia (1969) concluded that saturation 
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sensitivity is equivalent to the difference between chromatic and achromatic sensitivity.  
Guth and Lodge (1973), in their description of a vector color model, also suggest that the 
ratio of chromaticity to overall sensitivity is predicted by saturation. 
Foutch and Peck (2005) also found significantly higher variability in females for 
the primary hues of blue, green, yellow, and red.  This is consistent with Volbrecht et al. 
(1997) and Kuehni (2001) in suggesting a within female effect on variability not present 
in males.  There was no effect of gender on the variability for all three non-primary hues 
(cyan, orange, and magenta). 
Gender differences have also been reported in perception of color after-images 
(Hoynga et al., 1979).  When subjects were shown brief colored or white flashes and 
asked to report the appearance and changes in afterimages, males perceived more 
movement in after-images, and there was an interaction effect of stimulus color with 
gender on after-image duration.  A similar study revealed shorter overall afterimage 
durations for females, but longer durations in response to long-wavelength flash stimuli 
(McGuiness and Lewis, 1976).  Females reported afterimages in response to a red 
stimulus twice as often as males, but less often for all other colors. 
While all of these studies suggest differences in color processing, there is debate 
over what mechanisms account for this gender dimorphism.  Some proposed mechanisms 
are discussed in the following section.  
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POSSIBLE MECHANISMS FOR GENDER DIFFERENCES 
Gender differences in neural transmission  
When the retina is stimulated by light, amacrine cells release the neurotransmitter 
dopamine, modulating the neural processes leading to sensation (Feigenspan et al., 2000).  
Several studies have suggested that dopamine depletion that accompanies Parkinson’s 
disease leads to defects in contrast sensitivity (Masson et al., 1993), spatial processing 
(Diederich et al., 2002) and color discrimination (Büttner et al., 1994; Haug et al. 1995; 
Müller et al., 1997; Sartucci et al., 2003).  Other studies correlate dopamine function with 
gender and provide evidence that gender differences can result from retinal (originating 
in dopaminergic retinal neurons), thalamic (involving dLGN), or central (involving 
dopaminergic neurons in V1 and/or higher cortical areas) processes (Cowan et al., 2000; 
Yilmaz et al., 1998). 
In a blood-oxygen-level-dependent functional magnetic resonance imaging 
(BOLD fMRI ) study involving twenty (10 males, 10 females) age-matched subjects, 
Cowan et al. (2000) found significantly different gender responses to blue light in 
primary visual cortex.  Females had a 0.14% BOLD signal increase to both red and blue 
light, but males had only a 0.01% increase in BOLD signal to red light.  This difference 
was not significant at the p < 0.05 level.  Males did, however, have a 0.52% BOLD signal 
increase to blue light, which was significantly greater than the increase to blue light for 
females (p < 0.05).  The direction of the latter finding appears to contradict suggestions 
of a female physiological advantage in chromatic processing.  Levin et al. (1998) also 
found that males had higher BOLD fMRI signals than females in response to simple light 
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stimulation.  However, BOLD signals are complex.  While they are sensitive to blood 
oxygenation that accompanies increased activity, they depend on blood flow and tissue 
volume as well.  Therefore, they are better indicators of relative changes to baseline 
function. 
Cowan suggested that the entire difference could be due to sex-related retinal 
variations.  After all, dopamine receptors are present on all known retinal cell types 
(Nguyen-Legros et al., 1999).  However, dopamine receptors are also present in the 
thalamus (Mrzijak et al., 1996) and visual cortex (Berger et al., 1991), so central nervous 
system (CNS) alterations could occur as well.  It is not known how dopamine effects on 
the retina, thalamus, or CNS pathways contributed to the observed differences, as 
dopamine was not directly manipulated by Cowan nor were patients rigorously screened 
for conditions affecting dopamine function. 
 
Sex hormones and cyclical fluctuations  
Steroid sex hormone levels differ between males and females and are known to 
affect neurotransmitter function, including that of dopamine (Smith et al., 1987; Smith, 
1989).  Estrogen is a steroid hormone that has significant effects on both male and female 
reproductive systems.  Estrogens also regulate tissue functions outside of the reproductive 
system.  Estrogen receptor (ER) proteins mediate estrogen effects, and there are two 
subtypes of ERs, ERα and ERβ.  Ogueta et al. (1999) observed at least one type, ERα, in 
both male and female ocular structures, including the iris, lacrimal gland, choroid and 
retina. However, ERα proteins were found only in the retinas of premenopausal women, 
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not in men or in postmenopausal women.  These findings suggest the possibility of direct 
estrogenic influences on visual processing in pre-menopausal women. 
It is also possible that estrogens act through an intermediate mechanism. 
Estrogens influence dopamine release by augmenting glutamate and inhibiting gamma 
amino butyric acid (GABA) syntheses (Smith, 1989).  It is generally accepted that 
GABA-mediated cortical inhibition is important in determining visual responses (Zemon 
et al., 1986), and there is research attributing differences in visual processing abilities to 
sex hormones.  Diamond et al. (1972) found increased visual sensitivity to briefly 
presented broadband (white) lights during peak estrogen levels in women experiencing 
“normal cycles”, but not in age-matched males or women taking contraceptives that 
partially suppress the normal fluctuations in estradiol.  Yilmaz et al. (1998) found 
evidence for a facilitating effect of estrogen on visual neural transmission.  This study 
revealed significant decreases in latency and increases in amplitude of pattern reverse 
visual evoked potentials when estradiol levels peaked during the ovulatory phase of the 
menstrual cycle.  Ward et al. (1978) found that detection sensitivity to white stimuli on 
black backgrounds depended on the menstrual cycle phase of the woman.  Although the 
results were not well correlated with presumed estradiol levels, sensitivity was maximal 
during the menstrual phase, intermediate during the luteal phase, and minimal during the 
pre-ovulation phase.  A review by Parlee (1983) highlighted evidence for cyclical effects 
on visual processing.  In a later review of this research, Guttridge (1994) suggests there is 
an increased cortical capacity for visual information processing in women during peak 
estradiol levels of the menstrual cycle.  She concluded in her review that gender 
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differences in visual processing may be due to fluctuations in sex hormone levels during 
the menstrual cycle. 
Only a few studies have investigated the effects of the menstrual cycle on color 
vision.  Finkelstein (1887) found restricted color visual fields during the menstrual (low 
estradiol) phase of the menstrual cycle.  Finkelstein also reported an increase in the 
wavelength position of unique green (toward yellow) during the menstrual phase.  
Lorenzetti (1926) also found constricted red and green color fields with decreased yellow 
and green sensitivity during the menstrual phase.  While Guttridge (1996) could not 
demonstrate repeatable changes in standard achromatic visual fields across the menstrual 
cycle, other modern studies have linked the menstrual cycle to chromatic visual field 
changes.  The results of Akar et al. (2005) and Yucel et al. (2005) both agreed with those 
of Guttridge (1996) that standard achromatic automated perimetry (SAP) did not depend 
on the phase of the cycle.  However, both studies suggested decreased sensitivity to short-
wavelength stimuli during the relatively low estradiol luteal phase (p < 0.05 for both 
studies).  In a study of cyclical effects on isolated S-, M- and L-cone mechanisms, Eisner 
et al. (2004) found cyclical effects on S-cone mechanisms.  There were, however, only 
limited cyclical effects on M- and L-cone mechanisms. 
In addition to estrogen, progesterone is implicated in visual processing. 
Progesterone is thought to antagonize estrogens by increasing CNS sensitivity to GABA 
and decreasing the CNS response to glutamate (Smith, 1987).  Although the results have 
limited relevance to my current study, Phillips and Sherwin (1992) suggested that 
increased progesterone levels during the luteal phase limit visual memory.  More related 
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to my study are the results of Dunn and Ross (1985) who found improvements in contrast 
sensitivity during the luteal phase when progesterone/estradiol ratios are at their 
maximum.  Since the magnocellular pathway is sensitive to low contrast, this result 
possibly indicates a progesterone-related improvement in magnocellular function.  Kim 
and Tokura (1998) found that preferences for hue classes (“warm” vs. “cool”) depended 
on an interaction of ambient temperature and phase of menstrual cycle.  During the luteal 
phase (when progesterone is highest), warmer colors (reds) were preferred over cooler 
colors (blues) at warmer temperatures (28° C vs. 23° C). 
Finally, Kramer et al. (1996) implicate androgens (male sex hormones) in their 
demonstrated preponderance of “global bias” in boys compared to girls.  In describing 
large shapes made up of smaller geometrical elements, boys used more global 
descriptions (relying on the overall shape) whereas girls were more detailed (or local), 
referring to the smaller shapes to describe the figures.   However, I am unaware of any 
studies linking androgen levels to gender differences in color vision. 
 
Manifest heterozygosity of defective carriers 
Normal males have two sex chromosomes—one X-chromosome inherited from 
their mother and one Y-chromosome inherited from their father.  As a result, males are 
hemizygous (only one chromosome) for the expression of sex-linked color vision 
deficiencies and thus have either normal or abnormal color vision (Deeb, 2004).  Normal 
females differ from males in that they generally inherit two X chromosomes, one from 
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each parent.  Females can then be homozygous normal (XX) or heterozygous carriers 
(XX’), where X and X’ denote normal and abnormal genes, respectively, for color vision. 
Color vision deficiencies are recessive, sex-linked traits that generally involve amino acid 
substitutions or mutations on M- and L-cone gene opsins (Deeb, 2004).  Therefore, XY 
males are normal, and X’Y males express abnormal color vision.  With the exception of 
rare conditions involving multiple copies of X chromosomes in males, there is no 
intermediate state.  Females do have an intermediate state—manifest heterozygous 
carriers of color deficiencies. 
Approximately fifteen percent of human females are such carriers of sex-linked 
color deficiencies (Jordan and Mollon, 1993).   In theory, these individuals should have 
normal color vision since the normal color gene on one of their X chromosomes is 
dominant.  However, heterozygous carriers often exhibit mild color vision deficiencies on 
clinical testing (Jordon and Mollon, 1993).  Lyon (1963) hypothesized that heterozygous 
carriers are actually hemizygous in some cells due to X-inactivation during early 
development of the female embryo.  That is, one gene (normal or abnormal) is active at 
any given point during embryonic development of certain tissues.  In the eye, this results 
in a mosaic of normal and abnormal retina.  While some studies have suggested that 
heterozygous carriers have essentially normal trichromatic vision (Miyahara et al., 1998), 
others have found reduced luminous efficiency to long wavelength (Schmidt, 1955; 
Harris and Cole, 2005) or medium wavelength light (Crone, 1959) as well as deficient 
red-green discrimination (Krill and Schneiderman, 1964; Lang and Good, 2001; Hood et 
al., 2006).   
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Neitz and Jacobs (1986) suggested that the significant individual variation in 
color matches was due to polymorphism of L-cones in heterozygous carriers.  In his 
review of the question of gender and color, Mollon (1986) concluded there was evidence 
that the mutation provides carriers with a color vision advantage.  Since the substrate for 
color vision is the presence of multiple cone classes, a fourth cone class should improve 
color discrimination.  A study of this possible advantage revealed significantly greater 
delineation of spectral bands (i.e. more colors were seen) in heterozygous female carriers 
than in male or normal female trichromats (Jameson et al., 2001).  It is possible, then, that 
the results of previous studies indicating gender differences were influenced by 
undetected heterozygous carriers.  Because of this possibility, I used careful family 
history and examination of red-green discrimination to identify and exclude carriers from 
participation in the current study. 
 
PHOTOMETRIC METHODS 
Overall brightness, as well as the contributions from achromatic and chromatic 
channels, can be measured by photometric methods.  These methods consist of visually 
matching the illuminance produced by a test light source against the illuminance 
produced by a reference source.  Heterochromatic flicker photometry (HFP) is a 
technique that involves temporally alternating a monochromatic (narrowband) light with 
a reference broadband light at a relatively high (~20 Hz) rate.  The intensity of the test or 
colored stimulus is adjusted so that the perception of flicker is minimized.  After the 
observer has adjusted the intensity of the test (colored) stimulus to minimize flicker 
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perception, luminous efficiency is calculated.  This is the ratio of the maximum testable 
spectral radiance to that required to minimize flicker at that stimulus wavelength.  
Dividing each luminous efficiency by the maximum measured efficiency yields the 
relative sensitivity function for an observer. 
Since relative spectral sensitivity involves placing certain wavelengths in equal 
classes based on an assigned numerical value of light, all members of a class must have 
the same numerical value.  In this way, a class can be represented by a single member of 
that class and likewise be replaced by any other equivalent member of that class (Ives, 
1912).  To be considered equivalent, the measurements must first be additive.  That is, 
the mixture of two equiluminant colors must be of equal brightness and saturation to that 
of either of the original hues adjusted to twice its original value (Wagner and Boynton, 
1972).  A simpler approach is to say that if color C results from the mixture of two colors, 
A and B, the brightness of C should be equal to the sum of brightness A and brightness B.  
A second requirement of equivalence is that the measures are transitive.  If A and B are 
colors and match in brightness to a reference white, then A and B should match in 
brightness.  HFP measures are both additive and transitive, which is why results from 
flicker techniques played an important role in forming the standard luminous efficiency 
function, V(λ), frequently used in visual displays and calibrations (Lennie et al., 1993). 
The flicker rate in HFP can be manipulated to isolate the influence of chromatic 
vs. achromatic pathways.  Although rates vary for different wavelengths, one study 
suggested that the chromatic system is only fast enough to detect seven alternations per  
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second (Ikeda and Shimozono, 1978).  Beyond that alternation rate, equally bright 
flickering stimuli will appear to be continuous.  Achromatic processing is much faster, 
with critical (maximum) detectable flicker rates measured as high as 35-50 Hz, 
depending on the size and intensity of the test stimulus used (Hecht and Verrijp, 1933).   
HFP then isolates achromatic channels by staying below the critical flicker rate of the 
achromatic system (< 35 Hz) while avoiding influence of the chromatic channels (> 7 
Hz).  Generally accepted flicker rates for HFP are 18-25 Hz (Ikeda and Shimozono, 
1978). 
As noted above, slowly flickering systems involve a contribution of chromatic 
channels not detected by HFP techniques.  The theory is that slow successive matches 
(heterochromatic brightness matching or HBM) result in additivity failures due to an 
additional color opponent system not involved in minimum flicker detection (Guth and 
Lodge, 1973).  Differences in relative chromatic contributions along the spectrum also 
cause transitivity failures not found in HFP.  The interference of the opponent process 
causing these failures can actually be used to quantify the additional contribution of the 
chromatic channels (Guth and Lodge, 1973).  Either the difference (HBM-HFP) or the 
ratio (HBM/HFP) can be used as the “chromatic contribution” metric (Sagawa and 
Takahashi, 2001).   
Provided an observer maintains the “same brightness” criterion, it is reasonable to 
assume that the chromatic channel influence on brightness would be maximized if the 
colored and reference stimuli are presented simultaneously.  Direct brightness matching 
(DBM) is a photometric technique that involves simultaneous side-by-side (or up-and-
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down) presentation of two stimuli in a bipartite field separated by a small gap.  In DBM 
experiments, the observer adjusts the intensity of the colored field until it matches the 
reference field in perceived brightness.  This technique seems to be more intuitive than 
slow successive matches.  Although DBM measures are less repeatable (Meyer et al., 
1978) and more subject to daily shifts in criteria (Yaguchi et al., 1993) than HFP 
measures, they yield greater sensitivities than HFP in the blue (short wavelength) and red 
(long wavelength) portions of the spectrum (Guth and Lodge, 1973).  In the current 
study, I used the ratio of DBM to HFP as a measure of the contribution of chromaticity to 
brightness. 
 
GOALS AND HYPOTHESES 
In this study, I investigated the potential difference in chromatic processing 
between genders by comparing DBM/HFP ratios collected at five wavelengths—450 nm, 
520 nm, 560 nm, 580 nm, and 650 nm (perceived as the hues blue, green, yellow-green, 
yellow and red).  I predicted higher DBM/HFP ratios in females for the “primary” 
wavelengths: 450 nm, 520 nm, 580 nm, and 650 nm.  No such prediction was made for 
the yellow-green (560 nm) stimulus, which was included in the study as a normalizing 
stimulus.  I predicted there would be no gender effect on DBM measures in the present 
experiment.  This prediction was based on the work of Crawford (1948), who found no 
gender differences in threshold spectral sensitivity.  I also predicted there would be no 
gender difference in HFP measures on repeated measures or at any wavelength.  This 
prediction was based on the results of Foutch and Peck (2006) and a post-hoc gender 
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analysis of Harrington et al. (2004), both suggesting that HFP measures do not depend on 
gender.   
I also investigated the within females effects of hormone levels and menstrual 
phase on DBM/HFP ratios as well as HFP and DBM measures.  I predicted a significant 
positive correlation of DBM/HFP with estradiol/progesterone ratios for all four “primary” 
wavelengths.  I also predicted that DBM/HFP ratios would be at a maximum during the 
ovulatory phase, intermediate during the menstrual phase and minimum during the luteal 
phase.  This prediction was based on the balance of previous studies suggesting an 
increase in chromatic sensitivity during the ovulatory phase and a decrease during the 
luteal phase.  In my opinion, the balance of previous findings suggests very limited 
cyclical changes in HFP or absolute threshold measures.  Therefore, I predicted there 
would be no significant relationships of HFP and DBM measures with either hormone 
levels or menstrual cycle phase. 
 
 
Foutch, Brian, 2007, UMSL, p. 30 
METHODS 
SUBJECTS 
 Subjects were recruited by convenience, and informed consent was obtained from 
13 males and 21 females using separate consent forms.  All volunteers were paid for 
participating.  Subjects were eligible if they were between 18 and 45 years old, self-
reported a complete eye examination within the last twelve months, had best-corrected 
visual acuity of 20/25 or better in each eye, and had normal color vision tested with 
psuedoisochromatic plates and Farnsworth D-15 color panels.  Subjects were ineligible if 
they had a self-reported history of neurological or psychiatric disorders, used medications 
or nutritional supplements known to affect color vision, or had a family history of color 
defective vision.  Female subjects were ineligible if they had abnormal color 
discrimination on Medmont C-100 or Nagel anomaloscope testing.  In addition, female 
subjects were ineligible if they were menopausal or pregnant.  Use of hormonal 
contraceptives was permissible.  Tobacco use was allowed for all subjects if the number 
of pack years was below ten years, the amount previously shown to affect color 
sensitivity or discrimination (Erb et al., 1999; Bimler and Kirkland, 2004).  The 
institutional review board of the University of Missouri –St. Louis approved the 
experimental protocol.   
On selection, each female volunteer was asked if they were using oral 
contraceptives or intrauterine device (IUD).  They were also asked if they were willing to 
disclose the date of the first day of menses for their current menstrual cycle.  Two women 
were not willing to discuss details of their menstrual cycle and were placed in group I.  
 
Foutch, Brian, 2007, UMSL, p. 31 
Sixteen women were willing to disclose the first day of menses and were placed in group 
II for data collection and analysis.  Of the 16 subjects in group II, 7 subjects used either 
oral contraceptives or device that delivered exogenous estrogen and/or progesterone.  Six 
subjects were taking combination oral contraceptives containing progestational and 
estrogenic compounds.  Another subject was using a levonorgestrel intrauterine system.  
This system, also known as a progestin IUD, contains only progestin, a synthetic form of 
progesterone. 
  
SCHEDULING 
Men and group I women scheduled a single experimental session at their 
convenience.  On selection, female subjects in group II were asked to estimate the date of 
day 1 (first day of menses) of their current menstrual cycle.  The goal was to schedule 
experimental sessions to most closely coincide with postulated markers of minimum, 
intermediate and maximum estradiol/progesterone (E2/Pg) ratios.  These markers are 
minimum E2/Pg = day 21, maximum E2/Pg = days 12-13, and intermediate  = days 1-7 
(see Figure 3).  Experimental sessions were scheduled to most closely coincide with these 
markers.  The dates were stored in a spreadsheet and recorded on a post-card.  The post 
card was given to the subject as a reminder of scheduled experimental sessions.  Each 
group II participant also recorded day one of the second (DO2S) and third (DO3S) 
menstrual cycles on her post-card, which was returned when all experimental sessions 
were completed.  Some participants chose to email DO2S and/or DO3S dates rather than 
return the card. 
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Figure 3 – Changes in steroid sex hormone plasma levels during a typical menstrual 
cycle.  The solid line represents estradiol levels, and the dashed line represents 
progesterone levels.  Days 1-7 correspond to the menstrual phase where both hormone 
levels are at a minimum, but the ratio of estradiol to progesterone is intermediate.  
Ovulation (release of ovum or egg from ovary) occurs around day 13 and is preceded by 
peak estradiol levels while progesterone levels remain low.  The estradiol/progesterone 
ratio is maximized around days 11-12 just prior to ovulation.  Progesterone levels then 
rise during the luteal phase until they peak around day 21 of the cycle.  Estradiol levels 
decrease after ovulation then increase to a second peak also around day 21, where the 
estradiol/progesterone ratio is at a minimum compared to menstrual and ovulation phases.  
Note the different scales for estradiol and progesterone levels.  (The figure is adapted and 
redrawn from Odell and Moyer, 1971.) 
 
It is known that the length of the typical menstrual cycle from ovulation to 
menstrual phase is 14 days, but the length from start of menses to ovulation varies a great 
deal between women (Mozkowski et al., 1962).  It has also been shown that peak 
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estrogen levels occur on average 34 hours prior to ovulation or 15.5 days prior to the start 
of the next cycle (Pauerstein et al., 1978).  Mid-luteal phase was considered to occur at 
the midpoint between ovulation and the start of the next cycle.  Therefore, I counted back 
16 days (for peak E2/Pg near ovulation) and 7 days (for minimum E2/Pg at mid-luteal 
phase) from the expected start of the next cycle to determine ideal dates for data 
collection.  Although all sessions were used for all subjects, DO2S and DO3S were used 
for discussion to determine how closely the experimental sessions tied to menstrual, 
ovulatory, and mid-luteal phases.   
If an experimental session could not be scheduled or was not completed within 
three days of a predicted marker, that session was rescheduled during the second month.  
Several measurements were necessary during the second month, and the day within the 
cycle was verified by the first day of the third cycle (DO3S).  If the ideal date of 
ovulatory or mid-luteal phase fell on Sunday, the session was scheduled for Monday.  
The same scheduling process was used for all female subjects in group II, but scheduling 
sessions for oral contraceptive users was more straightforward as the length of the 
menstrual cycle is fixed at 28 days.  Two subjects could not complete three sessions 
within two cycles, and partial data (one and two sessions, respectively) were used in the 
analysis. 
 
HORMONE ANALYSIS 
On selection, female subjects in group II were provided three saliva collection kits 
(ZRT Laboratory, Beaverton, OR).  Each was instructed to collect saliva at home on the 
 
Foutch, Brian, 2007, UMSL, p. 34 
day of each experimental session.  Subjects were instructed to collect saliva in a small 
vial prior to eating, drinking or brushing their teeth and then to bring the collected sample 
to the session.  When a subject forgot to collect or bring the sample, she was instructed to 
collect and return the sample the following day.  Although sex hormone levels have been 
proven relatively stable in saliva (Dabbs, 1991), subjects were asked to refrigerate the 
samples until returned since the vials contained no preservative.  The day they were 
received, each sample was mailed to the laboratory for assay.  Progesterone and progestin 
were measured with a direct competitive radioimmunoassay (RIA), while naturally 
occurring and synthetic estradiol were measured by double antibody RIA.  All samples 
were analyzed within 30 days of collection as recommended by the laboratory.  Results 
were received from the laboratory by email and recorded in a spreadsheet for analyses. 
 
APPARATUS 
A three-channel optical (open-view) system was used to produce a 2-degree, 
circular field for both experimental tasks.  A uniform circular field was used for 
heterochromatic flicker photometry (HFP), while a side-by-side bipartite field was used 
for direct brightness measures (DBM). 
Splitting the output light 99:1 from a 1000-watt Xenon arc lamp through an 
antireflective window formed two illumination channels.  The first channel was a 
monochromatic test channel that consumed approximately 99% of the lamp output.  The 
intensity of the test channel was adjusted with an iris aperture and a motorized, computer-
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controlled set of dual counter-rotating variable neutral density filters.  A motorized, 
computer-controlled narrow bandpass interference filter (NBIF) wheel produced each of                         
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Figure 4 – Three channel optical system: The solid white and green lines represent 
Channel 1 before and after passing through narrowband interference filters, respectively.  
The dotted line represents Channel 2, which produces a broadband reference stimulus 
merged with Channel 1 for flicker photometry.  The dashed line represents Channel 3, 
which is presented simultaneously with Channel 1 for direct brightness matching (DBM).  
Components include A) 1000 Watt Xenon arc lamp, B) heat absorbing lens, C) 99/1 
beam splitter, D) variable iris apertures, E) dual counter-rotating variable neutral density 
filter system, F) narrow band pass interference wheel, G) mirrored optical chopper, H) 
diffusing optic cylinders for viewing stimuli, I) chin rest, J) front surface mirrors, K) 
variable neutral density filter,  L) channel 2/3 selector, M) narrow band interference filter 
wheel controller, N) dual counter-rotating variable neutral density filter system controller.  
Several focusing/condensing lenses were placed throughout optical channels but are not 
labeled.  A personal computer (PC) interfaced with M and N and was used for data 
acquisition and reduction. 
 
the five test wavelengths.  The second channel was a spectrally broad reference channel 
that consumed approximately 1% of the bulb output.  The intensity of the reference 
channel was adjusted using a variable neutral density filter and an iris aperture.  The 
reference channel was then split into two channels via a front surface mirror that could be 
translated in and out of the reference beam.  With the mirror in place for the HFP task, 
 
Foutch, Brian, 2007, UMSL, p. 36 
the test and reference beams were spatially merged yet temporally separated via a 
remote-controlled mirrored optical chopper rotating at 18 cycles/sec (Hz).  The test and 
reference beams alternately illuminated a 0.75-inch magnesium chromate (acrylic) 
cylinder.  Optically frosted ends of the cylinder acted to reduce variations in stimulus 
intensity and served as a diffuse circular viewing screen. 
The mirror was translated out of the reference beam to form a third channel used 
in the DBM experiments.  A fixed front surface mirror reflected the reference beam onto 
the left viewing half of a bipartite viewing field, separated from the monochromatic test 
field by a 0.5 mm-thick sheet of aluminum.  The fused and whole cylinders were part of a 
calibrated, mounted set that was remotely translated depending on task.  A chin rest was 
used to position each subject 17 inches from the viewing end of the optic–which 
subtended 2.5° of visual angle.  A detailed photograph of the experimental apparatus is 
shown in Figure 4. 
 
CALIBRATION 
 Since relative sensitivity at each wavelength is the reciprocal of the radiance 
required to match the reference stimulus (DBM) or minimize flicker sensation (HFP), 
reliable measures of relative sensitivity depend on accurate measures of spectral radiance.   
Since time did not permit a direct measurement of each stimulus after each trial, stimulus 
radiance was calculated from filter wheel settings for each of the five wavelengths.  The 
filter wheel controller provided the angle of rotation of the counter-rotating neutral 
density filters (from 50° to 330°).  In order to obtain a radiance measure from these 
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settings, the output angle was calibrated to luminance using a Photo Research 650 (PR-
650) spectroradiometer for every 10th degree shown on the output controller (i.e. 50°, 
60°, 70°, … 310°, 320°, 330°).   
Luminance was then modeled to filter settings according to the following 
equation: , where L = luminance, FS = filter setting in degrees, and (k,α) 
are parameters of the exponential model.   Each wavelength was modeled for three 
empirically derived ranges: Model I = (80 ≤ FS ≤ 200), Model II = (210 ≤ FS ≤ 250), and 
Model III = (FS > 250).  Each model provided a nearly ideal correlation (R
)(* FSekL α−=
2 ≈ 1.00) for 
all five wavelengths (Figure 5).  The only exception was with model I for the 450 nm 
stimulus.  In this case, the filter settings only accounted for 97% of the variance in 
luminance values (R2 = 0.97).  Random variance in luminance from this lack of fit (3%) 
would be well below the expected effect size for gender differences.  For this reason, the 
regression model was not further modified. 
Each morning of data collection, the neutral density filter in channel 2 was used to 
adjust the reference luminance to 5.0 cd/m2, measured using the spectroradiometer.  
Channel 1 luminance was also adjusted to 5.0 cd/m2 with the NBIF wheel in the open 
(broadband) position.  This level of luminance corresponded to a range of 100-200 retinal 
Trolands and ensured reliable, uniform cone contributions to both achromatic and 
chromatic systems (Lee, 1999) while staying in the recommended range for accurate HFP 
measures (de Vries, 1949).  In addition, the maximum measurable luminance and lamp 
radiometric output for each stimulus was measured weekly and recorded in a spreadsheet 
used to calculate relative sensitivity data.  This was important in calculating accurate 
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measures of spectral radiance required to match the reference stimuli, as repeated 
measures analysis of variance revealed differences over time in lamp radiometric output 
(F = 27.4, p < 0.01) and trends in maximum measurable luminance (F = 5.42, p < 0.1). 
Regression lines: Filter settings to Luminance
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Figure 5 – Regression lines of filter settings to logarithmic values of luminance.  For 
model I, R2 = 1.00 for all wavelengths except for 450 nm (R2 = 0.97).  For models II and 
III, R2 = 1.00 and 0.99, respectively, for all wavelengths. 
 
 
PROCEDURE 
Each subject completed a single practice session.  During this session, a minimum 
of four trials were performed at each test wavelength—450, 520, 560, 580 and 650 nm—
for both HFP and DBM tasks.   The practice concluded when the range of trials at each 
wavelength fell within one standard deviation (SD) of the mean for both DBM and HFP 
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measures.  This process was repeated until the subject was successful at making reliable 
sets of matches at all five test wavelengths for both methods. 
Prior to each experimental session, a random number generator was used to 
determine the order of task and wavelength presentation. Each session began by adapting 
each subject to the background room luminance (< 0.4 cd/m2) for at least five minutes. 
Subjects then practiced DBM and HFP matches while the Xenon bulb was allowed to 
warm up for at least thirty minutes.  Before and after each set of trials, the subject 
adapted for thirty seconds to a broadband reference stimulus. This accomplished two 
things.  It reduced selective bleaching from the previous narrowband stimulus and 
avoided the Purkinje shift in relative sensitivity to lower wavelengths due to low 
background and room luminance (Cornsweet, 1970).  After adapting to the reference 
fields, subjects adjusted the intensity of the test stimulus until it matched the reference 
field (for brightness measures) or the flicker sensation was minimized (for flicker 
photometry measures).  Pressing RECORD on the custom dual filter controller 
transferred the filter setting into a temporary spreadsheet (Excel, Microsoft Corporation, 
Redmond, WA).  Custom software (Redd Software Inc., Glen Carbon, IL) then remotely 
decreased the filter wheel setting by a randomly determined value between 50 and 100 
degrees (approximately 1-2 log units of intensity).  Four trials were performed for each 
stimulus in succession and followed by another thirty-second adaptation period.  This 
process was repeated for all five wavelengths for both tasks. 
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DATA REDUCTION AND ANALYSES 
The filter settings were imported into an Excel spreadsheet and then converted 
into transmission values using the calibration regression equations.  The transmission 
values from the filter settings on the four trials were averaged and divided by the 
maximum measurable luminance at the respective wavelength.  The proportion of the 
maximum luminance at each wavelength provided a percent-transmission that was 
multiplied by the lamp radiometric output (in watts/cd-m2) at each tested wavelength to 
yield the radiance required for match. 
Measures of macular pigment optical density (MPOD) were used in adjusting the 
DBM and HFP measures for the 450nm stimulus.  MPOD for each subject was measured 
with a commercial tabletop heterochromatic flicker photometer using a 1˚ circular 460 
nm stimulus (QuantifEYE, Zeavision LLC, Chesterfield, MO).  Since optical density 
(OD) is expressed by log 10(1/T), where T is transmittance, both HFP and DBM measures 
at 450 nm were multiplied by 10MPOD.  Due to scheduling difficulties, the instrument was 
unavailable for use at times convenient or even possible for some subjects.  When this 
occurred, the HFP and DBM measures for the 450 nm stimuli were not analyzed.  
However, the DBM/HFP ratio measures were analyzed since 10MPOD is present in both 
the numerator and the denominator.   
All HFP, DBM and MPOD measures along with the date of the session were 
copied into a single Excel spreadsheet. The aggregate data were then copied into SPSS 
(SPSS for Windows, SPSS Inc., Chicago, IL) and R (R Programming Language, Free 
Software Foundation, Boston, MA) statistical packages for analysis.  The HFP curves for 
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each subject were visually inspected for the presence of significantly reduced sensitivity 
to the 650 nm stimulus (Schmidt’s sign), which is evidence of a manifest heterozygous 
protan defect.  The contribution of chromaticity to brightness was calculated two ways, 
both involving the ratio of DBM to HFP measures.  The non-standardized ratios were the 
ratios of the radiances required for match of HFP to DBM measures.  The standardized 
ratios were the ratios of standardized DBM to standardized HFP measures.  Factor 
analysis was used to determine if a single factor representing chromatic contribution to 
brightness across all wavelengths could account for a significant amount of the variance 
in each ratio.  Modern item response theory (IRT) was also used to determine which 
ratio—standardized or non-standardized—was more suitable for use as a measure of 
chromatic contribution to brightness. 
Based on the results of factor analysis and item response theory, non-standardized 
ratios were chosen to represent chromatic contribution to brightness.  For the between-
subjects design, DBM/HFP ratio measures from the first session for all subjects were 
analyzed by repeated-measures analysis of variance (ANOVA) with gender and 
contraceptive use as fixed factors.  For the within-female analysis, only data from Group 
II female subjects were used for analyzing correlations of appropriate DBM/HFP ratios 
with estradiol, progesterone and estradiol/progesterone ratios.  I further analyzed the 
effects of hormone by regressing DBM/HFP ratios onto hormone levels and 
contraceptive use.  Lastly, I investigated the effects of menstrual phase and contraceptive 
use on DBM/HFP ratios by univariate ANOVA.  All correlation, regression and variance 
analyses were repeated for HFP and DBM measures. 
 
Foutch, Brian, 2007, UMSL, p. 42 
RESULTS 
HORMONE ANALYSES 
 I obtained 45 saliva samples from 16 subjects, and they were assayed for 
progesterone and estradiol concentrations.  Two samples from contraceptive users had 
estradiol concentrations below measurable levels (< 0.5 pg/ml), and eighteen 
progesterone concentrations were below measurable levels (< 15 pg/ml).  Ten of the low 
progesterone measures were from subjects not using any contraceptive device, and the 
remaining eight were from contraceptive users.  Another subject had an isolated high 
progesterone measure (2602 pg/ml) indicating a contaminated sample.  This measure was 
treated as an outlier and not used in the analysis.  Mean estradiol was 1.18 ± 0.64 pg/ml 
(range, 0.50 - 3.90 pg/ml).  Because estradiol measures were positively skewed and 
kurtotic, estradiol measures were log-transformed for analysis.  E2 will then refer to log-
transformed estradiol measures.  PG will refer to progesterone, which was distributed 
normally with a mean of 36.15 ± 21.24 pg/ml (range, 15-96 pg/ml).   
For non-contraceptive users, the average length of the menstrual cycle was 28.9 ± 
2.5 days (range, 25-32 days).  The length of the menstrual cycle was normalized for each 
subject to 28 days, and the day of the cycle was re-calculated based on the normalized 
length.  For example, subject 28 had a cycle length of 25 days, and her experimental 
sessions fell on days 6, 11, and 19 of her menstrual cycle.  When the length of her cycle 
was normalized to 28 days, the days were re-scaled to days 7, 12, and 21.   
Progesterone and estradiol measures for all subjects are plotted against the 
menstrual cycle phase in Figure 6.  Estradiol measures for contraceptive users and non-
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contraceptive users were coincident on profile analysis (F = 1.69, p > 0.2) but changed 
across menstrual phases (F = 12.9, p < 0.01).  Mean E2 was at a minimum during 
menstrual phase (days 0-8) with a small peak during luteal phase (around day 20).  
However, E2 did not peak for non-contraceptive users as expected (Odell and Moyer, 
1971) near ovulation (days 10-15).  This was either due to subjects being non-ovulatory 
or saliva collection not coinciding with peak estradiol levels.   
Only two subjects (one contraceptive user and one non-user) had usable 
progesterone measures for all three phases, therefore progesterone profiles could not be 
analyzed by repeated measures.  Using a univariate ANOVA design with contraceptive 
use and phase as fixed factors, progesterone measures were significantly higher for non-
contraceptive users than contraceptive users (F = 5.23, p = 0.03).  There was no main 
effect of phase or interaction of phase with contraceptive use.  Mean progesterone was at 
a minimum for non-contraceptive users during the menstrual and ovulatory phases (days 
0-15) and peaked as expected during the luteal phase (Odell and Moyer, 1971).  For 
contraceptive users, progesterone levels were at a minimum during menstrual phase but 
peaked during mid-cycle.  Because of these results, contraceptive use was considered as a 
factor in all subsequent analyses of photometric measures. 
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Figure 6 - Estradiol and progesterone profiles (in pg/ml) across the menstrual cycle 
phase.  Estradiol profiles were coincident for contraceptive users and non-users (F = 1.69, 
p > 0.2) and changed across menstrual phase (F = 12.9, p < 0.01).  There were not enough 
progesterone data to analyze the profiles across the menstrual phase.  However, there was 
a significant difference in progesterone levels between contraceptive users and non-
contraceptive users (F = 5.23, p = 0.03) using univariate ANOVA. 
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EXPERIMENTAL MEASURES 
Thirteen male subjects and two female subjects in group I completed a single 
practice session.  Sixteen female subjects in group II completed 45 experimental sessions.  
Sixteen, twelve and seventeen sessions were completed during menstrual, ovulatory and 
luteal phases, respectively.  Because distributions of standardized heterochromatic flicker 
photometry (HFP) data were platykurtotic and negatively skewed, HFP measures were 
log-transformed for analysis.  Since a decrease in luminous efficiency to red light 
(Schmidt’s sign) can be evidence of a manifest heterozygous protan defect, HFP 
measures were compared to the standard luminous efficiency function,V(λ), at 650 nm.  
HFP measures at 650 nm were within 0.1 log unit of V(λ), indicating that Schmidt’s sign 
was not observed.  Standardized direct brightness matching (DBM) measures were 
normally distributed and were not transformed for analysis.  Distributions for 
standardized and non-standardized DBM/HFP ratios were positively skewed and 
leptokurtotic and were log-transformed for analysis.  For the rest of this paper, HFP will 
refer to log-transformed standardized HFP data, and DBM will refer to standardized 
DBM data. 
Confirmatory factor analysis (CFA) was performed on DBM/HFP ratios using the 
data from the first session of all subjects, and two factors were extracted for the 
standardized ratios.  One factor was composed of variance components from the 450 
(blue) and 580 nm (yellow) stimuli and accounted for 34% of the variance in 
standardized ratios.  A second factor was composed of variance components from the 
560, 580 and 650 nm stimuli and accounted for an additional 20% of variance.  Variance 
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in measures from the 520 nm stimulus did not contribute significantly to either factor for 
standardized ratios.  A single factor was extracted for non-standardized ratios.  Each 
wavelength contributed significantly to the factor and cumulatively explained 50% of the 
variance. 
For item response theory (IRT) analysis, both ratios were scaled from 1.0 to 7.0 
then rounded to the nearest integer.  A dichotomous response was assigned to each scaled 
integer response:  0 (“not seen”) = 1, 2 and 1 (“seen”) = 3, 4, 5, 6, 7.  MULITLOG 
(Scientific Software International, Inc., Lincolnwood, IL) was then used to model these 
dichotomous data.  MULTILOG modeled chromatic contribution to brightness as a latent 
trait to the probability of endorsing (or “seeing”) the stimulus according to the following 
equation: 
 
]1[
1)1()( )( iie
ccP iii βθαθ −−+−+=  
 
where P = probability of endorsing item, i = item or wavelength, θ = latent trait 
(chromatic contribution to brightness), α = discrimination of items, β = difficulty of 
items, and c = guessing parameter of each item.  The results from MULITLOG revealed 
no improvement in model fits using the α and c parameters.  This suggested that the 
probability of guessing correctly was zero (c = 0), and each wavelength ideally 
discriminated whether or not the item was endorsed (α = 1).  The only difference 
between the items was the difficulty of the items or where on the continuum of the latent 
trait the probability functions fell.     
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As the model pertains to the current experiment, the latent trait represented the 
chromatic contribution to brightness.  Easier items (wavelengths) had higher ratios than 
more difficult items.  The resulting difficulty parameters from MULTILOG were input 
into a modified Excel spreadsheet (MODFIT, IRT Modeling Lab, University of Illinois) 
where predicted probability functions were fit against randomly sampled dichotomized 
ratios used as validation data.  The non-standardized ratios fit much more closely to 
validation data than standardized ratios.  The χ2 values for both ratios are summarized in 
Table 1, and the cumulative probability functions of observed and validation data are 
shown in Figure 7. 
 
Table 1 – IRT model fits to validation data (χ2 results) 
Wavelength Standardized Non-standardized 
450 188 3.31 
520 765 0.14 
560 189 0.02 
580 15.0 0.07 
650 51.8 0.35 
 
In general, χ2 values of < 3.0 indicate that an item is acceptable in the test of a 
latent trait (Bock, 1972; Mislevy, 1986).  Except for 450 nm, χ2 results for all of the non-
standardized ratios were in the acceptable range for use in an overall test of the latent 
trait.  Values for the standardized ratios were not acceptable, ranging from 15 to 188.  
These results were consistent with those from factor analysis, where the 520 nm stimulus 
did not contribute to either factor describing the variance in standardized ratios.  The χ2 
results for the 520 nm stimulus suggest that the 520 nm stimulus contributed very little 
information to the overall standardized test of the latent trait.  The 580 nm stimulus 
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contributed significantly to both factors, and its lower χ2 result suggests that it also 
contributed the most to the overall standardized model of the latent trait. 
Based on the results of factor analysis and IRT, non-standardized ratios were 
more suitable than standardized ratios for use as a measure of chromatic contribution to 
brightness.  For the rest of this paper, DBM/HFP ratios will refer to log-transformed non- 
standardized ratios. 
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Figure 7 – Cumulative probability plots of standardized and non-standardized ratios.  
Probability was plotted against the latent trait (chromatic contribution to brightness), and 
it is easy to see that the observed curves (circles) for non-standardized ratios fit more 
closely to validation curves (lines) than did standardized ratios.  In addition, the non-
standardized curves fell along a wider range of the latent trait while the standardized 
ratios all fell along higher levels of the latent trait.   These graphs, combined with the 
results of χ2 tests, indicate that non-standardized ratios were more suitable than 
standardized ratios for use as a measure of chromatic contribution to brightness. 
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MACULAR PIGMENT OPTICAL DENSITY (MPOD) MEASURES 
Males tended to have higher MPOD measures than females (t = 1.422, p = 0.17).  
This is consistent with Hammond et al. (1996) who found even greater differences in 
MPOD measures (p < 0.001).  In the current study, the distributions of MPOD were also 
similar to those of Hammond.  Distributions in both studies tended to be skewed 
negatively for females and positively for males.  In the current study, MPOD negatively 
correlated (as expected) with both HFP (r = -0.62, p = 0.003) and DBM (r = -0.55, p = 
0.01) measures at 450 nm.  Both measures were modeled at 450 nm to account for 
MPOD by multiplying sensitivity by 10MPOD.  After adjustment, MPOD correlated 
neither with HFP (r = -0.30, p = 0.19), DBM (r = -0.10, p = 0.68) nor DBM/HFP ratios at 
450 nm (r = 0.14, p = 0.55).   
 
ANTAGONISM OF L- AND M-CONE MECHANISMS AT 580 nm 
DBM/HFP ratios drop to unity around 580 nm.  This drop in sensitivity is known 
as the “Sloan notch” after Louise Sloan who first encountered the phenomenon (Sloan, 
1928).  Due to L- and M-cone antagonism near 580 nm, there is no additional 
contribution to brightness from chromaticity.  In the present experiment, as shown in 
Figure 8, the antagonism actually subtracts from sensitivity as measured by HFP at 580 
nm (i.e. DBM/HFP < 1.0).  DBM/HFP ratios at 580 nm were significantly less than 1.0 
for both males (t = -7.432, p < 0.001) and females (t = -2.814, p = 0.01).  In addition, 
DBM/HFP ratios at 580 nm for males were significantly less than those for females  
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(t = -3.722, p = 0.001).  The antagonism of L- and M-cones has been described as 
forming a mechanism distinct from that which forms V(λ) at wavelengths above 580 nm 
(Calkins et al., 1992), and this mechanism appears to be gender dimorphic. 
 
ANALYSIS I - BETWEEN-SUBJECTS DESIGN: GENDER COMPARISON 
The results of the between-subjects analysis of gender on experimental measures 
are shown in Figures 8-10 and summarized in Table 2.  As shown in Figure 8, female 
subjects had higher overall DBM/HFP ratios than male subjects (F = 15.4, p = 0.001), 
and the effect size (η2) was large (36%; see Table 2).  Multivariate ANOVA (MANOVA) 
also revealed higher ratios for females at every wavelength except 560 nm.  There was no 
effect of gender on overall HFP measures (F = 0.32, p = 0.58), nor was there an effect on 
HFP at any wavelength (Figure 9).  Gender also did not have a significant effect on 
overall DBM measures (F = 1.27, p = 0.27). 
 
Table 2 – Between-subjects effects of gender on experimental measures 
 DBM/HFP 
RATIO HFP DBM 
Wavelength F p η2 F p η2 F p η2
ALL *15.4 <0.01 0.36 0.32 0.58 0.02 1.27 0.27 0.04 
450 *9.51 <0.01 0.25 0.11 0.75 0.01 0.98 0.34 0.05 
520 *14.8 <0.01 0.35 0.07 0.80 0.00 3.35 0.08 0.15 
560 2.44   0.13 0.08 0.60 0.45 0.03 0.38 0.55 0.02 
580 *12.3 <0.01 0.31 0.45 0.51 0.02 0.03 0.87 0.00 
650 *5.95   0.02 0.18 0.01 0.91 0.00 1.78 0.20 0.09 
  * p < 0.05 
 
 
Foutch, Brian, 2007, UMSL, p. 51 
 
650 600 550 500 450 
wavelength 
10 
1 
0 
DB
M
/H
FP
 R
A
TI
O
 
DBM/HFP Ratio 
FEMALE MALE
 
  
A B 
  ** 
   * 
  ** 
  ** 
Error bars: ± 95% CI 
 
Figure 8 - Gender comparisons of DBM/HFP ratios.  Female subjects had higher ratios 
than males on repeated measures.  Multivariate analysis also revealed significantly higher 
ratios for females at all wavelengths except 560 nm (* p < 0.05, ** p < 0.01).  In Figures 
8-10, the scatter data (A) are plotted against interval wavelengths while the line data (B) 
are plotted against categorical wavelengths.  The different plotting methods account for 
the different shapes of the trend lines. 
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Figure 9 - Gender comparisons of heterochromatic flicker photometry (HFP) data from 
first experimental sessions.  There was not a significant difference between males and 
females by repeated measures ANOVA (F = 0.32, p = 0.58), nor were there significant 
differences at any wavelength on multivariate analysis.  
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Figure 10 - Gender comparisons of direct brightness matching (DBM) data from first 
experimental sessions.  There was not a significant difference between males and females 
by repeated measures ANOVA (F = 1.27, p = 0.27).  The greatest difference was at 520 
nm (F = 3.35, p = 0.08). 
 
ANALYSIS I - CONTRACEPTIVE USERS VS.  NON-CONTRACEPTIVE USERS 
As shown in Figure 6, there were differences in progesterone profiles between 
contraceptive users and non-contraceptive users across the menstrual cycle.  Since a 
possible mechanism for gender differences involves main and interaction effects of 
estradiol and progesterone, the between-subjects effects of contraceptive use were 
examined.  Comparisons of DBM/HFP ratios, HFP and DBM measures by contraceptive 
use are shown in Figure 11, and the results of repeated measures ANOVA are 
summarized in Table 3.  Unlike gender, contraceptive use had no effect on overall 
DBM/HFP ratios or at any particular wavelength.  There was also no main effect of 
contraceptive use on overall HFP measures (F = 1.05, p = 0.37), although MANOVA 
revealed that HFP measures tended to be higher for non-contraceptive users at 450 nm  
(F = 3.72, p = 0.08, η2 = 0.27). 
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Table 3 – Between-subjects effects of contraceptive use on experimental measures 
                         DBM/HFP RATIO          HFP            DBM 
Wavelength F p η2    F p η2     F p η2
ALL 0.04 0.84 0.00 1.05 0.37 0.11 2.49 0.15 0.20 
450 0.04 0.85 0.00 3.72 0.08 0.27 3.11 0.11 0.24 
520 0.36 0.56 0.03 0.46 0.51 0.04 0.61 0.45 0.06 
560 0.88 0.37 0.06 0.69 0.42 0.07 *7.03 0.02 0.41 
580 0.14 0.72 0.01 0.36 0.57 0.03 0.67 0.42 0.07 
650 1.16 0.30 0.08 0.59 0.46 0.06 0.42 0.53 0.04 
* p < 0.05 
 
Contraceptive use accounted for 27% of the variance in HFP at 450 nm, but less 
than 10% at all other wavelengths.  Though not significant (F = 2.49, p = 0.15), the effect 
size of contraceptive use on overall DBM measures was large (η2 = 0.20).   DBM 
measures tended to be higher for non-contraceptive users at 450 nm (F = 3.11, p = 0.11), 
while contraceptive users had significantly higher DBM measures at 560 nm (F = 7.03, p 
= 0.02). 
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* 
Error bars: ± 95% CI 
 
 
 
 
Figure 11 – DBM/HFP, HFP, and DBM measures by contraceptive use.  Unlike gender, 
contraceptive use had no effect on overall DBM/HFP ratios or at any particular 
wavelength.  Contraceptive users actually had higher DBM measures at 560 nm (F = 
7.03, p = 0.02), which accounted for 41% of the variance.  (* p < 0.05) 
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ANALYSIS II – CORRELATION AND REGRESSION ANALYSIS OF  
                DBM/HFP RATIOS AND HORMONE MEASURES 
 
For this investigation of the within females effects of hormone levels and 
menstrual phase on DBM/HFP ratios, I predicted a significant positive correlation 
between DBM/HFP and E2/PG ratios for all four primary wavelengths (450, 520, 580 
and 650 nm).  All experimental sessions from group II were used, and the correlations of 
DBM/HFP ratios with hormone measures for all Group II subjects are summarized in 
Table 4.  One-tailed tests were used as I predicted a priori significant positive 
correlations.  DBM/HFP ratios are plotted against hormone levels in Figures 12-14.  The 
only significant correlation was at 650 nm (R = 0.33, p = 0.05).  
 
 
Table 4 – Correlations of DBM/HFP ratios with hormone measures: All subjects 
 
ALL GROUP II SUBJECTS 
  MEASURE                                      E2                 PG            E2/PG 
Pearson’s R 0.08 0.04 0.21 RATIO 450 Sig (1-tailed) 0.31 0.43 0.16 
Pearson’s R -0.13 -0.14 0.03 RATIO 520 Sig (1-tailed) 0.21 0.26 0.45 
Pearson’s R -0.05 -0.02 0.03 RATIO 560 Sig (1-tailed) 0.41 0.46 0.45 
Pearson’s R -0.08 -0.13         -0.07 RATIO 580 Sig (1-tailed) 0.31 0.27 0.36 
Pearson’s R 0.01 0.19        *0.33 RATIO 650 Sig (1-tailed) 0.48 0.19 0.05 
         
* p = 0.05 
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Figure 12 – DBM/HFP ratios plotted against estradiol levels for all Group II subjects.  
There were no significant relationships.  NOTE:  Color coding, as shown in the legend, 
will apply to Figures 12-37. 
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Figure 13 – DBM/HFP ratios plotted against progesterone levels for all Group II 
subjects. There were no significant relationships. 
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Figure 14 – DBM/HFP plotted against E2/PG ratios for all Group II subjects. There was 
a significant relationship at 650 nm (R = 0.33, p = 0.05). 
 
 
As with the between-subjects analysis, data from contraceptive users and non-
contraceptive users were analyzed separately.  Correlations of DBM/HFP ratios with 
hormone levels by contraceptive use are shown in Table 5.  Two-tailed tests were used as 
no prediction was made a priori concerning the direction (+/-) of the correlations by 
contraceptive use.  The only correlation approaching significance was between the 
DBM/HFP ratio at 450 nm and progesterone levels (R = 0.52, p = 0.09) for contraceptive 
 
Foutch, Brian, 2007, UMSL, p. 59 
users.  The correlation of DBM/HFP with E2/PG ratios was positive for contraceptive 
users and negative for non-contraceptive users at every wavelength, as shown in Figure 
15. 
 
Table 5 – Correlations of DBM/HFP ratios with hormone measures by contraceptive use 
 
                                                    NON-CONTRACEPTIVE USERS        CONTRACEPTIVE USERS 
  MEASURE                                       E2           PG        E2/PG                     E2          PG       E2/PG 
Pearson’s R 0.11 -0.14 -0.01 0.08  0.52 0.38  RATIO 450 Sig (2-tailed) 0.60 0.64 0.97 0.77  0.09 0.20 
Pearson’s R -0.15 -0.16 -0.16 0.28 -0.26 0.36  RATIO 520 Sig (2-tailed) 0.47 0.59 0.58 0.26  0.42 0.22 
Pearson’s R -0.18 0.01 -0.30 0.24 -0.03 0.41 RATIO 560 Sig (2-tailed) 0.40 0.98 0.28 0.34  0.94 0.16 
Pearson’s R -0.10 -0.17 -0.32 0.07  0.29 0.17 RATIO 580 Sig (2-tailed) 0.67 0.57 0.25 0.77  0.36 0.59 
Pearson’s R 0.05 0.11 -0.04 0.03 -0.02 0.37 RATIO 650 Sig (2-tailed) 0.82 0.72 0.90 0.91  0.95 0.22 
 
 DBM/HFP Ratio Contraceptive users Non-contraceptive users 
0.01 0.005 0.00 -0.005 -0.01 -0.015 -0.02 
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Figure 15 – DBM/HFP plotted against E2/PG ratios by contraceptive use.  There were no 
significant relationships. 
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 In order to further examine the effects of hormone levels and contraceptive use on 
DBM/HFP ratios, regression analysis of DBM/HFP ratios onto E2, PG and contraceptive 
use was performed according to the following equation:  DBM/HFP = a0 + b1E2 + b2PG + 
b3E2xPG + c1CONT + c2CONTxE2 + c3CONTxPG + c4CONTxE2xPG, where E2 = estradiol, 
PG = progesterone and CONT = contraceptive use.  Variables were entered in the order 
they appear in the regression equation.  The final regression model was chosen based on 
the ANOVA model (i.e. maximum F-value).  This method was chosen over maximizing 
the effect size (R2), since all added variables will increase the effect size even if they 
worsen the ANOVA model.  The results—with only significant predictors shown—are 
summarized in Table 6. 
 
Table 6 – DBM/HFP ratios regressed onto hormone levels and contraceptive use 
 * - standardized coefficient; no predictive value in regression equation 
OVERALL MODEL 
MEASURE F p R2 PREDICTOR COEFF           t               p 
CONSTANT (a0) 0.54 4.82 0.00 
E2 1.28 2.14 0.05 
E2*PG -0.05 -2.88 0.01 
RATIO 450 2.33 0.07 0.49 
CONT*E2*PG 0.07 2.20 0.04 
E2 1.34 2.92 0.01 
PG 0.01 2.31 0.03 
RATIO 520 4.79 0.01 0.41 
E2*PG -0.05 -3.70 0.00 
CONSTANT (a0) -0.15 -2.28 0.03 
E2 0.93 2.49 0.02 
PG 0.01 2.59 0.02 
RATIO 560 3.52 0.03 0.33 
E2*PG -0.03 -3.12 0.01 
RATIO 580 -- -- -- CONT*E2*PG  (*0.61 2.67 0.01) 
CONSTANT (a0) 0.29 2.60 0.02 
E2 1.63 3.02 0.01 
PG 0.01 3.59 0.00 
E2*PG -0.06 -4.11 0.00 
RATIO 650 7.55 0.00 0.60 
CONT*PG  -0.01 -2.22 0.04 
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At 580 nm, the three-way interaction of CONT x E2 x PG was significant only 
when considered as an excluded variable.  That is, hormone levels and/or contraceptive 
use did not combine to significantly predict DBM/HFP ratios at 580 nm.  Regression 
equations can be written to predict DBM/HFP ratios at all other wavelengths.   
 
In matrix form, the equations are: 
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The previous regression analysis ignores all information about PG and its 
interaction with E2 and contraceptive use for nineteen missing PG measures.  An 
alternative approach is to dichotomize progesterone measures based on the median level 
(i.e. treat progesterone as below or above median) and regress DBM/HFP ratios onto 
estradiol by dichotomized progesterone levels and contraceptive use.  The results of this 
analysis reveal a positive relationship between E2 and DBM/HFP ratios for non-
contraceptive users when PG was below median level with a significant effect at 580 nm 
(R2 = 0.45, p = 0.05).  The trend was opposite (negative) for non-contraceptive users 
when PG was above median level.  For contraceptive users, there was a positive 
relationship between E2 and DBM/HFP ratios when PG was above median level.  The 
results were mixed for contraceptive users when PG was below median levels.  There 
was a positive relationship between E2 and DBM/HFP ratios for 520 nm and 560 nm but 
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a negative trend at 450, 580, and 650 nm (no significant models).  These results are 
shown in Figure 16. 
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Figure 16 – DBM/HFP ratios plotted against E2 by dichotomized progesterone levels 
and contraceptive use.  The only significant finding is at 580 nm for non-contraceptive 
users with PG levels below median (plotted in bold).  There also appears to be an overall 
interaction effect of estradiol level with both contraceptive use and progesterone level. 
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ANALYSIS II – EFFECTS OF MENSTRUAL PHASE AND CONTRACEPTIVE  
               USE ON DBM/HFP RATIOS 
 
 An alternate method of analysis is to consider the effect of menstrual phase on 
DBM/HFP ratios.  Univariate ANOVA was used to determine the effects of menstrual 
phase and contraceptive use on DBM/HFP ratios, and the results are summarized in  
Table 7.  I predicted that DBM/HFP ratios would be at a maximum during the ovulatory 
phase, intermediate during the menstrual phase and minimum during the luteal phase.  
However, I made no predictions by contraceptive use.   
 
Table 7 – Effects of menstrual phase and contraceptive use on DBM/HFP ratios 
OVERALL MODEL 
MEASURE F p R2 FACTOR F               p                 η
2
PHASE 0.51 0.61 0.03 
CONT 0.22 0.64 0.01 
 
RATIO 450 
  
0.62 
  
  
0.69 
  
  
0.08 
  PHASE * CONT 1.03 0.37 0.05 
PHASE 0.95 0.40 0.05 
CONT 0.66 0.42 0.02 
 
RATIO 520 
 
0.49 
  
 
0.78 
  
 
0.06 
  PHASE * CONT 0.06 0.94 0.00 
PHASE 0.47 0.63 0.03 
CONT 0.21 0.65 0.01 
 
RATIO 560 
 
0.26 
  
 
0.93 
  
 
0.03 
  PHASE * CONT 0.16 0.85 0.01 
PHASE 0.20 0.82 0.01 
CONT 0.00 0.98 0.00 
 
RATIO 580 
 
0.27 
  
 
0.93 
  
 
0.04 
  PHASE * CONT 0.45 0.64 0.02 
PHASE 0.73 0.49 0.04 
CONT 5.86 0.02 0.14 
 
RATIO 650 
 
2.56 
 
0.04 
 
0.26 
PHASE * CONT 2.95 0.07 0.14 
 
The only significant findings were at 650 nm where the overall ANOVA model 
was significant (F = 2.56, p = 0.04, R2 = 0.26).  Non-contraceptive users had higher mean 
DBM/HFP ratios across the menstrual cycle (F = 5.86, p = 0.02, η2 = 0.14), and there was 
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an interaction of contraceptive use with menstrual phase (F = 2.95, p = 0.07, η2 = 0.14).  
These results are shown in Figure 17.   
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Figure 17 – DBM/HFP ratios plotted against menstrual phase for all five wavelengths.  
Menstrual phase and contraceptive use combined to predict a significant proportion of the 
variance (R2 = 0.26) in DBM/HFP ratios at 650 nm (F = 2.56, p = 0.04).  There were no 
main effects of phase on DBM/HFP ratios at any wavelength, but non-contraceptive users 
had higher DBM/HFP ratios than contraceptive users at 650 nm (F = 5.86, p = 0.02, η2 = 
0.14).  The interaction between contraceptive use and menstrual phase approached 
significance at 650 nm (F = 2.95, p = 0.07, η 2 = 0.14).  During the luteal phase, non-
contraceptive users had significantly higher DBM/HFP ratios than contraceptive users at 
650 nm (t = 3.57, p = 0.003).  There were no other simple effects of contraceptive use at 
any menstrual phase.  
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There was not a significant change across the menstrual cycle at any wavelength.  
However, during the luteal phase, non-contraceptive users had higher DBM/HFP ratios 
than contraceptive users at 650 nm (t = 3.57, p = 0.003).  The significant findings at 650 
nm are shown in Figure 18. 
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Figure 18 – DBM/HFP ratios at 650 nm plotted against menstrual phase.  Menstrual 
phase and contraceptive use combined to predict a significant proportion of the variance 
(R2 = 0.26) in DBM/HFP ratios (F = 2.56, p = 0.04).  Non-contraceptive users had higher 
DBM/HFP ratios than users (F = 5.86, p = 0.02, η2 = 0.14), and the interaction between 
contraceptive use and menstrual phase approached significance (F = 2.95, p = 0.07, η 2 = 
0.14).  During the luteal phase, non-contraceptive users had significantly higher 
DBM/HFP ratios than contraceptive users (t = 3.57, p = 0.003). 
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As in previous studies of menstrual cycle effects on visual function (Akar et al., 
2005; Yucel et al., 2005), the menstrual cycles was divided into two halves.  The 
follicular phase represents days 1-14 when both mean estradiol and progesterone are low, 
and the luteal phase represents days 15-28 when mean estradiol and progesterone are 
generally higher.  Figure 19 shows DBM/HFP profiles for all wavelengths across 
dichotomized menstrual phase by contraceptive use.   
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Figure 19 – DBM/HFP ratios plotted against dichotomized menstrual phase for all five 
wavelengths.  Non-contraceptive users had higher DBM/HFP ratios than contraceptive 
users at 650 nm (F = 9.36, p = 0.004, η2 = 0.19).  There was also a significant interaction 
between contraceptive use and menstrual phase at 650 nm (F = 8.36, p = 0.01, η2 = 0.18).  
During the luteal phase, non-contraceptive users had significantly higher DBM/HFP 
ratios than contraceptive users at 650 nm (t = 3.97, p = 0.001).  There were no other 
simple effects of contraceptive use at either dichotomized phase.  
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Figure 20 – DBM/HFP ratios at 650 nm plotted against dichotomized menstrual phase.  
Overall, menstrual phase and contraceptive use combined to predict a significant 
proportion of the variance (R2 = 0.30) in DBM/HFP ratios (F = 5.51, p = 0.003).  There 
was a significant difference between contraceptive users and non-contraceptive users (F = 
9.36, p = 0.004, η2 = 0.19).  There was also a significant interaction between 
contraceptive use and menstrual phase (F = 8.36, p = 0.01, η2 = 0.18).  During the luteal 
phase, non-contraceptive users had significantly higher DBM/HFP ratios than 
contraceptive users (t = 3.97, p = 0.001). 
 
 
Univariate ANOVA was used to determine the effects of dichotomized phase and 
contraceptive use on DBM/HFP ratios.  As with scaled phase, the only significant 
findings were at 650 nm where the overall ANOVA model was significant (F = 5.51, p = 
0.003, R2 = 0.30).  Non-contraceptive users again had higher mean DBM/HFP ratios 
across the menstrual cycle at 650 nm (F = 9.36, p = 0.004, η2 = 0.19).  There was also a 
significant interaction (F = 8.36, p = 0.006, η2 = 0.18) of contraceptive use with 
dichotomized menstrual phase at 650 nm as shown in Figure 19.  Although there was not 
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a significant change across the dichotomized menstrual cycle for any wavelength, 
DBM/HFP ratios at 650 nm for contraceptive users tended to be lower during the luteal 
phase.  In addition, during the luteal phase, non-contraceptive users did have higher 
DBM/HFP ratios than users at 650 nm (t = 3.97, p = 0.001).  The significant findings at 
650 nm are shown in Figure 20. 
 
 
ANALYSIS II – CORRELATION AND REGRESSION ANALYSIS OF  
                            HFP WITH HORMONE MEASURES 
 
Correlations of HFP with hormone measures for all group II subjects are shown in 
Table 8.  HFP measures are plotted against hormone levels in Figures 21-22.  As 
predicted, none of the correlations between HFP and hormone measures were significant 
at the p < 0.05 level. 
 
Table 8 – Correlations of HFP measures with hormone levels: All subjects 
                                       ALL GROUP II SUBJECTS 
MEASURE                                            E2                 PG           E2/PG 
Pearson’s R    -0.10 0.32 -0.22 HFP 450 
Sig (2-tailed) 0.51 0.11  0.26 
Pearson’s R -0.08 -0.04 -0.23 HFP 520 Sig (2-tailed) 0.62 0.84  0.24 
Pearson’s R 0.15 0.17  0.26 HFP 560 Sig (2-tailed) 0.35 0.40  0.18 
Pearson’s R 0.12 0.07  0.25 HFP 580 Sig (2-tailed) 0.43 0.74  0.19 
Pearson’s R 0.09 0.20  0.04 HFP 650 Sig (2-tailed) 0.57 0.34  0.84 
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Figure 21 – HFP measures plotted against estradiol and progesterone levels for all Group 
II subjects.  There were no significant relationships. 
 
 
 
                         
Figure 22 – HFP measures plotted against E2/PG ratios for all Group II subjects.  There 
were no significant relationships. 
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Correlations of HFP measures with hormone levels by contraceptive use are 
shown in Table 9.  For non-contraceptive users, HFP measures significantly correlated 
with E2 measures at 580 nm (r = 0.41, p = 0.05) and with E2/PG ratios at 560 nm (r = 
0.51, p = 0.05) and 580 nm (r = 0.70, p < 0.01).  For contraceptive users, HFP measures 
did not correlate significantly with hormone levels at any wavelength.  The effects by 
contraceptive use are shown in Figure 23. 
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Figure 23 – HFP measures plotted against E2/PG ratios by contraceptive use.  E2/PG 
ratios significantly predicted HFP measures for non-contraceptive users at 560 nm (F = 
4.56, p = 0.05, R2 = 0.26) and 580 nm (F = 12.61, p = 0.004, R2 = 0.49), both plotted in 
bold.  There were no significant relationships for contraceptive users. 
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Table 9 – Correlations of HFP measures with hormone levels by contraceptive use 
                                                                   NON-CONTRACEPTIVE USERS      CONTRACEPTIVE USERS 
  MEASURE                                       E2              PG          E2/PG            E2      PG   E2/PG 
Pearson’s R -0.10 0.16 -0.16 -0.18 0.19 -0.47    HFP 450 
Sig (2-tailed) 0.63 0.59 0.56 0.48 0.55 0.11 
Pearson’s R 0.01 -0.01 -0.49 -0.16 0.36 0.11    HFP 520 Sig (2-tailed) 0.98 0.98 0.07 0.53 0.25 0.73 
Pearson’s R 0.16 0.33  *0.51 0.31 0.24 0.17 HFP 560 Sig (2-tailed) 0.43 0.25 0.05 0.22 0.44 0.57 
Pearson’s R    *0.41 0.15  **0.70 -0.20  -0.38 -0.21 HFP 580 Sig (2-tailed) 0.05 0.61 0.00 0.43 0.22 0.50 
Pearson’s R 0.19 0.09 0.09 0.03 0.46 -0.01 HFP 650 Sig (2-tailed) 0.36 0.76 0.75 0.92 0.14 0.97 
* p < 0.05,  ** p < 0.01 
The main and interaction effects of continuous hormone levels and contraceptive 
use on HFP measures were then examined using multiple regression.  The regression 
results, with significant predictors shown, are summarized in Table 10. 
 
Table 10 – HFP measures regressed onto hormone levels and contraceptive use 
 
OVERALL MODEL 
MEASURE F p R2 PREDICTOR  COEFF             t              p 
CONSTANT  -0.13 -4.29 0.00 
E2   0.81 5.57 0.00 
PG     0.002 3.23 0.01 
E2*PG  -0.02 -4.85 0.00 
CONT    0.11 2.08 0.05 
CONT*E2   -0.43  -4.24 0.00 
HFP 580 6.42 0.00 0.68 
CONT*PG -0.004 -2.21 0.00 
 
Hormone levels and/or contraceptive use only combined to significantly predict 
HFP measures at 580 nm (F = 6.42, p < 0.001, R2 = 0.68), and the regression equation 
can be written as:  HFP 580 = - 0.013 + 0.81 x E2 + 0.002 x PG + 0.02 x E2 x PG + CONT x  
(0.11 + 0.43 x E2 – 0.004 x PG). 
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 The results of regressing HFP measures onto estradiol, dichotomized progesterone 
levels, and contraceptive use reveal mixed effects of E2 on HFP measures.  For non-
contraceptive users, when PG was below median level, E2 significantly predicted HFP 
only at 520 nm (R2 = 0.44, p = 0.03).  There were no other significant effects for non-
contraceptive users.  For contraceptive users, there was a negative trend of E2 on HFP 
measures when PG was above median level, although there were no significant effects.  
There appeared to be a negligible effect of E2 at any wavelength for contraceptive users 
when PG was below median level (see Figure 24). 
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Figure 24 – HFP measures plotted against E2 by dichotomized PG levels and 
contraceptive use.  For non-contraceptive users, E2 significantly predicted HFP measures 
at 520 nm (plotted in bold) when PG was below median.  There were no significant 
relationships for contraceptive users, and estradiol appears to have had no effect at all on 
HFP measures when PG was below median levels.  
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ANALYSIS II – EFFECTS OF MENSTRUAL PHASE AND CONTRACEPTIVE  
                           USE ON HFP MEASURES 
 
 Figure 25 shows HFP profiles for all wavelengths across the menstrual cycle by 
contraceptive use.  Univariate ANOVA was used to determine the effects of menstrual 
phase and contraceptive use on HFP ratios.  The only notable trend was the main effect of 
contraceptive use at 450 nm (F = 3.48, p = 0.07, η2 = 0.12).  No overall ANOVA model 
was significant, and there was no main effect of menstrual phase at any wavelength.   
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Figure 25 – HFP measures plotted against menstrual phase by contraceptive use.  No 
effects were significant at p < 0.05 level, but HFP measures tended to be higher for non-
contraceptive users at 450 nm (F = 3.48, p = 0.07).  In addition, HFP measures tended to 
be higher for non-contraceptive users at 450 nm during both the menstrual phase (t = 
2.28, p = 0.06) and the luteal phase (t = 2.07, p = 0.06).  There were no other trends or 
simple effects of contraceptive use at any menstrual phase. 
 
Analysis of the simple effects of contraceptive use revealed that HFP measures 
tended to be higher for non-contraceptive users at 450 nm during both the menstrual 
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phase (t = 2.28, p = 0.06) and the luteal phase (t = 2.07, p = 0.06).  These trends at 450 
nm are shown in Figure 26. 
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Figure 26 – HFP measures at 450 nm plotted against menstrual phase by contraceptive 
use.  Although not significant at p < 0.05 level, HFP measures tended to be higher for 
non-contraceptive users (F = 3.48, p = 0.07).  In addition, HFP measures tended to be 
higher for non-contraceptive users at 450 nm during both the menstrual phase (t = 2.28,  
p = 0.06) and the luteal phase (t = 2.07, p = 0.06). 
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HFP profiles for all wavelengths across dichotomized menstrual phases by 
contraceptive use are shown in Figure 27.  Univariate ANOVA was used to determine the 
effects of dichotomized phase and contraceptive use on HFP ratios.  Non-contraceptive 
users had higher HFP measures than contraceptive users at 450 nm (F = 4.18, p = 0.05, η2 
= 0.12).  There were no main or interaction effects of dichotomized menstrual phase on 
HFP measures at any wavelength.   
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Figure 27 – HFP measures plotted against dichotomized menstrual phase by 
contraceptive use.  Non-contraceptive users had higher HFP measures at 450 nm (F = 
4.18, p = 0.05; plotted in bold on both graphs for comparison) and a trend toward higher 
HFP measures at 650 nm (F = 3.48, p = 0.07).  There was also a trend toward higher HFP 
measures for non-contraceptive users at 450 nm during the follicular phase (t = 2.09, p = 
0.06).  There were no other simple effects of contraceptive use on HFP measures at any 
wavelength. 
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During the follicular phase, HFP measures tended to be higher for non-
contraceptive users at 450 nm (t = 2.09, p = 0.06).  This trend is shown in Figure 28. 
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Figure 28 – HFP measures at 450 nm plotted against dichotomized menstrual phase by 
contraceptive use.  Non-contraceptive users had higher HFP measures (F = 4.18, p = 
0.05).  There was also a trend toward higher HFP measures for non-contraceptive users 
during the follicular phase (t = 2.09, p = 0.06). 
 
 
 
ANALYSIS II – CORRELATION AND REGRESSION ANALYSIS  
                           OF DBM WITH HORMONE MEASURES 
 
Correlations of DBM with hormone measures for all group II subjects are shown 
in Table 11.  DBM measures are plotted against hormone levels in Figures 29-30.   
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Table 11 – Correlations of DBM with hormone measures: All subjects 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ALL GROUP II SUBJECTS 
  MEASURE                                         E2                    PG           E2/PG 
Pearson’s R 0.06 0.34  0.00 DBM 450 
Sig (2-tailed) 0.70 0.09  0.99 
Pearson’s R -0.08 -0.22 -0.25 DBM 520 Sig (2-tailed) 0.62 0.28  0.21 
Pearson’s R 0.12 0.19  0.09 DBM 560 Sig (2-tailed) 0.43 0.35  0.65 
Pearson’s R 0.06 0.01 -0.07 DBM 580 Sig (2-tailed) 0.73 0.94  0.74 
Pearson’s R 0.25 **0.71 *0.40 DBM 650 Sig (2-tailed) 0.11 0.00   0.04 
* p < 0.05,  ** p < 0.01 
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Figure 29 – DBM measures plotted against estradiol and progesterone levels for all 
Group II subjects.  There was a positive relationship between DBM measures and 
progesterone levels at 650 nm (R2 = 0.51, p < 0.001; plotted in bold).  There was also a 
positive trend at 450 nm (R2 = 0.11, p = 0.09) 
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Figure 30 – DBM measures plotted against E2/PG ratios for all Group II subjects.  There 
was a significant positive relationship between DBM measures and E2/PG ratios at 650 
nm (R2 = 0.16, p = 0.04). 
 
 
Although I predicted there would be no significant relationships, DBM measures 
correlated significantly at 650 nm with PG measures (R = 0.71, p < 0.01; see Figure 29) 
and E2/PG ratios (R = 0.40, p = 0.04; see Figure 30).  DBM measures at 450 nm tended 
to positively correlate with PG levels (R = 0.34, p = 0.09; see Figure 29). 
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Correlations of DBM measures with hormone levels by contraceptive use are 
shown in Table 12.  For non-contraceptive users, DBM measures were significantly 
positively correlated with both E2 (R = 0.44, p = 0.03) and PG (R = 0.60, p = 0.02) at 650 
nm.  For contraceptive users, the only significant correlation was between DBM 
measures at 450 nm and PG measures (R = 0.60, p = 0.02). 
 
Table 12 – Correlations of DBM with hormone measures by contraceptive use 
                         NON-CONTRACEPTIVE USERS                                       CONTRACEPTIVE USERS 
  MEASURE                                     E2              PG            E2/PG             E2              PG          E2/PG 
Pearson’s R 0.17 0.15 0.08 -0.18   **0.60 -0.23    DBM 450 
Sig (2-tailed) 0.41 0.62 0.77 0.48 0.04   0.46 
Pearson’s R -0.07 -0.06 -0.29 ----     ---- ----    DBM 520 Sig (2-tailed) 0.74 0.83 0.29 ----     ---- ---- 
Pearson’s R 0.15 0.29 0.13 0.15 0.03   0.10  DBM 560 Sig (2-tailed) 0.47 0.32 0.65 0.57 0.92   0.74 
Pearson’s R 0.22 0.19 0.14 -0.20 0.08  -0.28  DBM 580 Sig (2-tailed) 0.28 0.52 0.62 0.43 0.80    0.35 
Pearson’s R  **0.44    **0.60 0.35 -0.14 0.45    0.43  DBM 650 Sig (2-tailed) 0.03 0.02 0.20 0.58 0.14    0.14 
* p < 0.1, ** p < 0.05, ---- unable to compute correlation due to constant DBM 520 
 
 
The main and interaction effects of continuous hormone levels and contraceptive 
use on DBM measures were then examined using multiple regression.  The regression 
results, with only significant predictors shown, are summarized in Table 13.  When 
considering the effects on DBM measures at 580 nm, the three-way interaction of CONT 
x E2 x PG was significant as an excluded variable (t = 2.67, p = 0.01).  However, 
hormone levels and/or contraceptive use only combined to significantly predict DBM 
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measures at 650 nm (F = 13.70, p < 0.001, R2 = 0.27).  The regression equation can be 
written as: DBM 650 = 0.27 + 0.27 x E2. 
 
Table 13 – DBM measures regressed onto hormone levels and contraceptive use 
OVERALL MODEL 
MEASURE F p R2 PREDICTOR COEFF             t               p 
DBM 580    CONT*E2*PG  (*0.61 2.67      0.01) 
DBM 650 13.70 <0.001 0.27 CONSTANT  0.27 14.77      0.00 
    E2  0.27 2.95      0.01 
    PG (*0.58 3.72      0.00) 
    CONT*PG (*-0.49 -3.26      0.00) 
* - standardized coefficient; no predictive value to regression equation 
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Figure 31 – DBM measures plotted against E2 by dichotomized progesterone levels and 
contraceptive use.  There were no significant findings at any wavelength for any 
condition, nor was there a systematic interaction of estradiol level with PG level or 
contraceptive use. 
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The results of DBM measures regressed onto estradiol, dichotomized 
progesterone levels, and contraceptive use are shown in Figure 31.  For non-contraceptive 
users, there was a positive trend of E2 on DBM measures at all wavelengths when PG 
was below median level, but there were no significant models.  When PG was above 
median level, there was a negative trend at 520 nm, but trends were positive at all other 
wavelengths.  For contraceptive users, E2 had mixed effects on DBM measures when PG 
was above or below median level; no relationships were significant. 
 
 
ANALYSIS II – EFFECTS OF MENSTRUAL PHASE AND CONTRACEPTIVE  
               USE ON DBM MEASURES 
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Figure 32 – DBM measures plotted against menstrual phase by contraceptive use.  DBM 
measures were higher for non-contraceptive users at 650 nm (F = 9.73, p = 0.00) but 
higher for contraceptive users at 560 nm (F = 4.20, p = 0.05), plotted in bold on both 
graphs.  Mean DBM measures also tended to be higher for contraceptive users at 520 nm 
(F = 3.37, p = 0.08).  During the luteal phase, DBM measures were higher for non-
contraceptive users at 650 nm (t = 3.41, p = 0.004), but there were no other simple effects 
at any wavelength. 
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Figure 32 shows DBM profiles for all wavelengths across menstrual cycle by 
contraceptive use.  Univariate ANOVA was used to determine the effects of menstrual 
cycle phase and contraceptive use on DBM measures, and the ANOVA results are 
summarized in Table 14. 
 
Table 14 – Effects of menstrual phase and contraceptive use on DBM measures 
OVERALL MODEL 
MEASURE F p R2 FACTOR F               p                 η
2
PHASE 0.29 0.75 0.02 
CONT 2.36 0.14 0.08 
 
DBM 450 
  
0.61 
  
  
0.69 
  
  
0.10 
  PHASE * CONT 0.01 0.99 0.00 
PHASE 0.02 0.98 0.00 
CONT 3.37 0.08 0.10 
 
DBM 520 
 
0.69 
  
 
0.63 
  
 
0.11 
  PHASE * CONT 0.04 0.96 0.00 
PHASE 1.29 0.29 0.08 
CONT 4.20 0.05 0.13 
 
DBM 560 
 
1.56 
  
 
0.20 
  
 
0.21 
  PHASE * CONT 0.62 0.55 0.04 
PHASE 0.49 0.62 0.03 
CONT 0.00 0.95 0.00 
 
DBM 580 
 
0.42 
  
 
0.83 
  
 
0.07 
  PHASE * CONT 0.66 0.53 0.04 
PHASE 1.23 0.29 0.08 
CONT 9.73 0.00 0.25 
 
DBM 650 
 
5.32 
 
0.001 
 
0.48 
PHASE * CONT 5.56 0.01 0.28 
 
There was no main effect of menstrual phase for all subjects at any wavelength, 
but there were main effects of contraceptive use at 560 nm (F = 4.20, p = 0.05; see Figure 
33), and 650 nm (F = 9.73, p = 0.004; see Figure 33).  In addition, the interaction of 
menstrual cycle phase and contraceptive use was significant (F = 5.56, p = 0.01, η2 = 
0.28), as was the overall ANOVA model at 650 nm (F = 5.32, p = 0.001, R2 = 0.48).  For 
non-contraceptive users, DBM measures at 650 nm were higher during the luteal phase 
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compared to the menstrual phase (t = 4.297, p < 0.001).  For contraceptive users, DBM 
measures at 560 nm were higher during the luteal phase compared to the ovulatory phase 
(t = 2.955, p = 0.013).  The only simple effect of contraceptive use was during the luteal 
phase, when DBM measures were higher for non-users at 650 nm (t = 3.41, p = 0.004).     
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Figure 33 – DBM measures at 560 nm and 650 nm plotted against menstrual phase by 
contraceptive use.  DBM measures at 560 nm were higher for contraceptive users (F = 
4.20, p = 0.05), but there were no simple effects of contraceptive use or menstrual cycle 
phase at 560 nm.  DBM measures were higher at 650 nm for non-contraceptive users (F = 
9.73, p = 0.00).  For non-contraceptive users, DBM measures at 650 nm were higher 
during the luteal phase than the menstrual phase (t = 4.297, p < 0.001).  During the luteal 
phase, DBM measures were also higher for non-contraceptive users at 650 nm (t = 3.41, p 
= 0.004).  Error bars represent 95% confidence intervals. 
 
 
DBM profiles for all wavelengths across dichotomized menstrual phases by 
contraceptive use are shown in Figure 34.  Univariate ANOVA was used to determine the 
effects of dichotomized phase and contraceptive use on DBM measures, and the results 
are summarized in Table 15.  Contraceptive users had higher overall DBM measures at 
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560 nm (F = 4.67, p = 0.04), but non-contraceptive users had higher DBM measures at 
650 nm (F = 13.31, p < 0.001).  In addition, for non-contraceptive users, DBM measures 
at 650 nm were higher during the luteal phase compared to the menstrual phase (t = 
4.297, p < 0.001).  When examined for simple effects of contraceptive use on DBM at 
particular phases, contraceptive users had higher DBM measures at 520 nm during the 
follicular phase (t = 2.10, p = 0.05) but lower at 650 nm during luteal phase (t = 3.81, p = 
0.002).  The significant findings are shown in Figures 35-37. 
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Figure 34 – DBM measures plotted against dichotomized menstrual phase by 
contraceptive use.  Contraceptive users had higher DBM measures at 560 nm (F = 4.67, p 
= 0.04), but non-contraceptive users had higher DBM measures at 650 nm (F = 13.31, p < 
0.001).  In addition, contraceptive users had higher DBM measures at 520 nm during 
follicular phase (t = 2.10, p = 0.05) but lower at 650 nm during luteal phase (t = 3.81, p < 
0.01).  The only simple effect of phase on DBM measures was at 650 nm.  For non-
contraceptive users, DBM measures at 650 nm were higher during the luteal phase 
compared to the follicular phase (t = 4.297, p < 0.001). 
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Table 15 – Effects of dichotomized menstrual phase and contraceptive use on DBM 
OVERALL MODEL 
MEASURE F p R2 FACTOR F               p                 η
2
LUTEAL PHASE 2.89 0.10 0.09 
CONT 2.94 0.10 0.09 
 
DBM 450 
  
2.05 
  
  
0.13 
  
  
0.17 
  PHASE * CONT 0.07 0.80 0.00 
LUTEAL PHASE 0.02 0.90 0.00 
CONT 3.34 0.08 0.10 
 
DBM 520 
 
1.20 
  
 
0.33 
  
 
0.10 
  PHASE * CONT 0.05 0.83 0.00 
LUTEAL PHASE 2.22 0.15 0.07 
CONT 4.67 0.04 0.13 
 
DBM 560 
 
2.38 
  
 
0.09 
  
 
0.19 
  PHASE * CONT 0.00 0.97 0.00 
LUTEAL PHASE 0.73 0.40 0.02 
CONT 0.03 0.87 0.00 
 
DBM 580 
 
0.45 
 
0.72 
 
0.04 
PHASE * CONT 0.90 0.35 0.03 
LUTEAL PHASE 1.67 0.21 0.05 
CONT 13.31 0.00 0.30 
 
DBM 650 
 
8.301 
 
<0.001 
 
0.445 
PHASE * CONT 10.63 0.00 0.26 
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Figure 35 – DBM measures at 520 nm plotted against dichotomized menstrual phase by 
contraceptive use.  There were no main effects of contraceptive use or menstrual phase, 
but contraceptive users had higher DBM measures at 520 nm during the follicular phase 
(t = 2.10, p = 0.05). 
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Figure 36 – DBM measures at 560 nm plotted against dichotomized menstrual phase by 
contraceptive use.  Contraceptive users had higher DBM measures at 560 nm (F = 4.67,  
p = 0.04), but there were no simple effects of contraceptive use or menstrual cycle phase. 
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Figure 37 – DBM measures at 650 nm plotted against dichotomized menstrual phase by 
contraceptive use.  For non-contraceptive users, DBM measures at 650 nm were higher 
during the luteal phase compared to the follicular phase (t = 4.297, p < 0.001). Contra-
ceptive non-users had higher DBM measures at 650 nm (F = 13.31, p < 0.001).  Contra-
ceptive users had lower DBM measures during the luteal phase (t = 3.81, p < 0.001). 
 
Foutch, Brian, 2007, UMSL, p. 87 
SUMMARY RESULTS 
As predicted, overall DBM/HFP ratios were higher for female subjects than male 
subjects.  Females also had higher DBM/HFP ratios at every wavelength except 560 nm.  
Unlike gender, contraceptive use had no effect on overall DBM/HFP ratios nor did 
contraceptive use have a significant effect on DBM/HFP ratios at any particular 
wavelength.  There was no main effect of contraceptive use on overall HFP measures or 
on overall DBM measures, but contraceptive users did have significantly higher DBM 
measures than non-contraceptive users at 560 nm. 
The only significant relationship between DBM/HFP ratios and E2/PG was at 650 
nm.  There were no significant relationships between HFP measures and hormone levels 
at any wavelength.  DBM measures at 650 nm significantly positively correlated with 
both PG and E2/PG.  When the correlations were analyzed by contraceptive use, there 
was an interesting interaction of E2/PG ratios and contraceptive use on DBM/HFP ratios.  
Although there were no significant findings, the correlation of DBM/HFP with E2/PG 
ratios was positive for contraceptive users and negative for non-contraceptive users at 
every wavelength.  For non-contraceptive users, HFP measures positively correlated with 
E2 levels at 580 nm and with E2/PG ratios at both 560 nm and 580 nm.   In addition, 
DBM measures positively correlated with both E2 and PG levels at 650 nm.  For 
contraceptive users, the only significant finding was the positive correlation between 
DBM measures and PG levels at 650 nm.  
Regression equations could be written to predict DBM/HFP ratios based on 
continuous hormone levels and contraceptive use at all wavelengths except 580 nm.  The 
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results were not as broad for HFP and DBM measures.  HFP measures were only 
predicted by hormone levels and contraceptive use at 580 nm, while E2 predicted DBM 
measures at 650 nm.  When the effect of E2 on DBM/HFP ratios was examined by 
dichotomized PG level and contraceptive use, E2 significantly predicted HFP measures at 
520 nm for non-contraceptive users when PG was below median level.   
There were limited effects of menstrual phase and contraceptive use on 
DBM/HFP ratios.  At 650 nm, non-contraceptive users had higher mean DBM/HFP ratios 
across the menstrual cycle.  There was also an interaction of contraceptive use with 
menstrual phase.  During the luteal phase, non-contraceptive users had higher DBM/HFP 
ratios than contraceptive users at 650 nm.  Non-contraceptive users also had higher HFP 
measures than contraceptive users at 450 nm, and there was a non-significant trend for 
higher HFP measures during the follicular phase.  DBM measures were higher for 
contraceptive users at 520 and 560 nm but higher for non-contraceptive users at 650 nm.  
The only simple effect of menstrual cycle was at 650 nm where DBM measures were 
higher during the luteal phase.
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DISCUSSION 
SUMMARY OF PURPOSE 
 Visual perception is a complex response resulting from genetics, experience, 
gender, hormone levels, learning and social influences.  It is therefore methodologically 
challenging to establish significant gender differences in human perception.  The results 
of this study add to the body of evidence that suggests a female advantage in chromatic 
processing.  The effect size of the overall between-gender comparison was very large, 
with gender accounting for 36% of the variance in chromatic contribution to brightness.  
This effect is on the order of the effect size (44%) of the well-accepted male advantage in 
spatial processing (Linn and Peterson, 1985).  The within-female effects of contraceptive 
use, hormone levels and menstrual cycle phase were not as robust and were limited to 
certain conditions and stimulus wavelengths.   
What follows is an examination of chromatic processing within the human visual 
system.  Current thought on organization and activation effects at each level of visual 
transformation will be applied to account for significant findings.  Novel approaches 
ranging from the treatment of the initial visual sensation as a purely physical problem to 
the role of family dynamics in perception will also be applied. 
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VARIABILITY IN HORMONE AND EXPERIMENTAL MEASURES 
 The within-female analysis depended on valid hormone measures.  Although care 
was taken to properly collect, store and deliver saliva samples (see Dabbs, 1991), there 
was considerably more variation in PG measures than in E2 measures.  This is in 
agreement with Chatterton et al. (2005) who found that standard errors in saliva measures 
of PG were an order of magnitude greater than standard errors in E2.  In addition, the 
expected peak in E2 levels near ovulation was not observed.  In the present study, 
observing more robust cyclical effects based on short-term activation influences of 
female steroid hormones might depend on making experimental measurements near peak 
E2 levels and would have required more frequent saliva sampling (see review by Kelly et 
al., 1999).  If females differ significantly from males during a short period of time during 
the cycle, there might be both a large between-gender effect and a cyclical effect that was 
missed in this analysis.  The limited hormone effects on experimental measures might 
also be due to large individual differences in hormone profiles across the menstrual cycle 
as demonstrated by Alliende (2002). 
There was greater variability in DBM measures than HFP measures, consistent 
with previous work (Meyer et al., 1978; Yaguchi et al., 1993).  Variability in DBM/HFP 
ratios was greater at short and long wavelengths relative to the more sensitive portion of 
the visual spectrum.  This is also consistent with previous findings (Guth and Lodge, 
1973; Yaguchi et al., 1993).  In the present study, I found that variability in DBM/HFP 
ratios was not significantly different between males and females. 
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ENDOGENOUS VS. EXOGENOUS HORMONE EFFECTS  
While the effects of contraceptive use on visual measures were limited in the 
present study, it is worthwhile to mention that synthetic progestin can affect the central 
nervous system differently than endogenous progesterone (reviewed by Glick and 
Bennett, 1981; Martin and Buono, 1997).  Mechanisms for the limited effects of 
contraceptive use in the present study may involve the different actions of endogenous 
and exogenous progesterone on target tissues.  The goal of most hormonal contraceptive  
devices is to inhibit ovulation.  When ovulation does not occur, the corpus luteum—a 
temporary organ responsible for progesterone production—stops secreting progesterone 
and decays (Bengtsson, 1971).  This reduction in progesterone could be responsible for 
some of the effects of contraceptive use found in the present study. 
 
GENDER AND HORMONE EFFECTS THROUGHOUT THE VISUAL SYSTEM 
Anterior segment 
 There is evidence in the literature for gender differences in anterior segment 
structures and organization.  In their study of visual acuity as a function of gender, hue 
and age, Kelton et al. (1978) found an interaction of gender with hue on visual acuity.  
They suggested that their findings were, in part, due to chromatic aberration.  However, I 
am unaware of any studies suggesting a directional difference in refractive error that 
could account for significant chromatic aberration differences between males and 
females.  In a large-scale study involving 2583 school-aged children, girls had more 
powerful corneas and lenses as well as deeper vitreal chamber depths while boys had 
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deeper anterior chambers and overall longer axial lengths (Zadnick et al., 2003).  There 
were, however, no significant gender differences in refractive error.   
There were strict visual acuity requirements in the present study (20/25 each eye), 
and all subjects had received a complete ophthalmic evaluation within the last 12 months.  
This requirement ruled out uncorrected hyperopia or accommodative problems that could 
lead to significant individual differences in chromatic aberrations.  These requirements, 
combined with the results of Zadnick et al., make it highly unlikely that organizational 
differences in the anterior segment could have significantly contributed to the large 
gender differences found in the current study. 
 In her review of ocular and visual changes during the menstrual cycle, Guttridge 
(1994) concluded there was at least “reasonable evidence” that the cornea was sensitive 
to female hormones.  The human cornea swells an average of 4.5% overnight, while the 
average post-ovulatory overnight change is 5.6% (Mertz, 1980).  It is possible that 
corneal swelling produced aberration effects responsible for a small portion of the limited 
cyclical effects.  However, a small difference in corneal swelling is not likely to have 
contributed significantly to the large between-gender difference in chromatic contribution 
to brightness found in the present study. 
 
Macular pigment optical density (MPOD) 
Based on the low correlations between DBM/HFP ratios and MPOD measures, it 
is reasonable to assume little to no contribution of MPOD to the large gender effect on 
DBM/HFP ratios.  However, Hammond et al. (1996) suggested cyclical changes in 
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MPOD measures.  In the present study, HFP measures at 450 nm did not change across 
the menstrual cycle.  MPOD was only measured once for each subject, so the possible 
effect of cycling MPOD cannot be evaluated. 
 
Photopigments and photoreceptors 
In the introduction, I discussed the possibility that inclusion of heterozygous 
carriers for protan or deutan color vision defects (CVD) might contribute to measured 
gender differences in chromatic sensitivity.  While it is possible that my screening 
regimen was insufficiently sensitive to exclude all carriers, it did detect three carriers out 
of twenty-one female volunteers.  This is consistent with the percentage of carriers (15%) 
in the female population (Neitz and Jacobs, 1986).  Even if carriers are present in the 
study, it is doubtful that the small advantage afforded them in color discrimination could 
significantly contribute to the overall gender effect on DBM/HFP ratios (36%).  
Considering that L- and M- cone mechanisms are minimally sensitive to short 
wavelengths, the effect of gender on DBM/HFP ratios at 450 nm (25%) can not be 
accounted for by L- and M- photopigment variations in CVD carriers.  It is also difficult 
to imagine how polymorphism of M- and L-cone photopigments could account for the 
within-females findings at 520, 560 and 650 nm. 
 It is generally accepted that the cone photoreceptor mosaic varies a great deal 
among genotypically normal individuals (Kimble and Williams, 2000).  However, 
Brainard et al. (2000) found that L/M cone ratios ranging from 0.25 to 9.0 resulted in 
virtually no differences in color perception.  Neitz et al. (2002) also found an “enormous 
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difference in estimated cone ratio, but no corresponding variation in color perception.”  
In addition, the results of Kimble and Williams (2000) revealed no gender differences in 
L/M organization.  Overall, there is a lack of support for the role of photoreceptor 
organization in the robust gender differences found in the present study.   
However, it may be reasonable to attribute some of the cyclical effects found in 
the present study to photoreceptor mechanisms.  Non-contraceptive users had 
significantly higher DBM/HFP ratios and DBM measures than contraceptive users at 650 
nm during the luteal phase.  In addition for non-contraceptive users, DBM measures at 
650 nm were significantly higher during the luteal phase than during the follicular phase.  
DBM measures at 650 nm were also positively correlated with PG levels and with E2/PG 
ratios. These findings are in agreement with those of Diamond et al. (1972) who found 
that non-contraceptive users had higher sensitivity to a small (subtending 1 minute of arc) 
white stimulus during the luteal phase compared to the follicular phase.   
It is possible that the presently observed effects at 650 nm may result from 
increased body temperature caused by the synergism of E2 with PG during the luteal 
phase (Forman et al., 1987).  In their treatment of visual sensations as the consequence of 
the physical properties of photoreceptors, St. George (1952) and Lewis (1955) reasoned 
that sensations to stimuli at wavelengths greater than 590 nm depended on temperature as 
well as stimulus lightness.  Although he studied rod photoreceptors, Lewis concluded 
there was a “fairly good” extension of the model at photopic levels.  On the premise that 
small amounts of long-wavelength light could only decompose thermally excited 
photopigment, de Vries (1948) also demonstrated that a 1° increase in core body 
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temperature (due to increases in ambient temperature) increased an observer’s threshold 
sensitivity to both 660 nm and 730 nm light.   
Jordan and Mollon (1993) argued that the results of Richter (1951), suggesting 
temperature-related seasonal changes in anomaloscope matches, were “wholly 
artefactual” as the findings could be accounted for by changes in instrument temperature.  
Instrument effects could not, however, explain the results of Kim and Tokura (1998) who 
used reflective color chips and found that during the luteal phase “redder” colors were 
preferred over “cooler” (blue and green) colors.  Jordan and Mollon’s criticism would 
also have little impact on the present results, as the instrumentation is not as susceptible 
to temperature changes.  However, since I did not measure body temperature, it is not 
possible to evaluate its effect on the results of the present study. 
   In the chain of events leading to visual perception, beyond photopigment 
decomposition, are ionic channels in the photoreceptor surface membrane that close and 
hyperpolarize the cell (see Baylor, 1996).  It is then possible that ionic changes in the 
photoreceptor environment could affect visual responses.  Increased absorption 
theoretically results in increased photoreceptor excitation, leading to increased release of 
neurotransmitter from photoreceptors.  This enhances the probability of a visual signal 
and decreases detection threshold.  Knowles (1980) found that the relative absorption of 
long wavelengths in chicken photoreceptors increased as serum concentrations of 
chloride ion increased.  Venkatesh et al. (2002) suggested that ion level changes during 
the menstrual cycle could be sufficient to affect visual sensitivity.  It is possible to 
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attribute a portion of the present findings at 650 nm to either cyclical temperature or ionic 
changes at the level of the photoreceptors. 
 Toker et al. (2003) revealed an influence of sex hormones on blood flow in 
retrobulbar arteries.  Blood flow resistance (BFR) decreased and peak systolic velocity 
(PSV) increased with increased estrogen levels.  The opposite occurred with increased 
testosterone levels (increased BFR and decreased PSV).  Estrogen was therefore 
beneficial to ocular hemodynamics, while testosterone antagonized the benefits of 
estrogen.  In a study designed to investigate the effects of blood flow on the suppression 
of L-cone flicker responses by an intense (103.8 retinal Trolands) 640 nm stimulus, Eisner 
and Samples (2003) found that flicker suppression was directly related to heart rate and 
inversely related to blood pressure.  It is then possible that gender differences in blood 
flow could have influenced the present findings. 
 
Post-receptor mechanisms 
HFP can be modeled with the non-opponent addition of L+M cone mechanisms 
(see Cavanagh et al., 1987), and the present findings at 580 nm could result from indirect 
cyclical changes in dopaminergic action on diffuse bipolar cells or their synapses with 
magnocellular ganglion (parasol) cells.  Such an idea would be an extension of previous 
studies linking dopamine with changes in luminance processes (Masson et al., 1993).  It 
has also been suggested that contrast sensitivity is different for cycling vs. non-cycling 
women (Johnson and Petersik, 1987).  In the present study, it is possible then that E2 
and/or PG acted directly or indirectly on luminance only (L+M) mechanisms. 
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For non-contraceptive users, there was a dependence of DBM/HFP ratios at 580 
nm on E2 levels when PG levels were low.  This result makes sense in the context of 
neurotransmitter release and function.  It is known that bipolar cells with combined L and 
M inputs release glutamate onto bistratified ganglion cells (Calkins and Sperling, 1999; 
Lee, 2004).  Since estrogens augment glutamate release (Smith, 1989), an increase in E2 
would increase the opponent L+M response.  This would particularly be the case when 
glutamate is not antagonized by PG (Smith et al., 1987). 
In long-term users of contraceptives, Marre et al. (1974) found tritan 
(blue/yellow) defects on FM-100 testing.  These results are in agreement with those of 
Eisner et al. (2004) who suggest that changes in S-cone pathways are associated with 
estrogen receptor activity in normal, cycling female subjects.  It is known that certain 
estrogen receptors, ERα, exist only in the retinal epithelium of pre-menopausal women 
(Ogueta et al., 1999).  It is possible that, as Eisner (2004) speculates, different subtypes of 
estrogen receptors affect different visual functions.  In the retina, S and L+M bipolar cells 
release different forms of glutamate (excitatory vs. inhibitory) onto synapses with 
bistratified ganglion cells, helping to establish +S-(L+M) or blue-yellow opponency.  In 
the present study, E2 levels affected HFP measures only at 580 nm.  However, E2 levels 
had a significant effect on DBM/HFP ratios at all wavelengths except 580 nm.  Therefore, 
it is possible that estrogen receptors are differentially distributed on ganglion cells and 
result in a “trade-off” between luminance and chromatic systems at this level. 
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Dorsal lateral geniculate nucleus (dLGN) of the thalamus  
It is well established that the thalamus is the primary color relay in the human 
visual system.  The robust gender differences of the present study are in agreement with 
the psychophysical work of Jacobs (1983a) who found that increment threshold 
differences between green (540 nm) and red (640 nm) stimuli were gender dimorphic in 
light-adapted squirrel monkeys.  In effect, male monkeys behaved in a protanomalous 
fashion when light-adapted.  Subsequent results of Jacobs (1983b) revealed a 
significantly higher proportion of spectrally opponent cells in dLGN of female monkeys 
than of male monkeys.  In addition, in male monkeys virtually every spectrally opponent 
cell (85 of 86) was coded for blue-yellow.  Jacobs’s findings may not extend beyond the 
studied population or to humans.  However, the results of factor analysis by gender in the 
present study, where a second factor in DBM/HFP ratios composed of variance 
components from the 520 nm (“green”) and 650 nm (“red”) stimuli was extracted for 
females but not males, are in agreement with the findings of Jacobs. 
 
Visual cortex: Primary (V1), Secondary (V2) and Visual area 4 (V4) 
While it has been suggested that there is color processing specialization within V1 
and V2 (Livingstone and Hubel 1987; 1988), the majority of these cells also respond to 
luminance differences (reviewed by Gegenfürtner and Kiper, 2003).  It is probably most 
accurate to describe the set of chromatic-sensitive cells in V1 and V2 as ranging in 
function from strict luminance processing to strict color opponency.  It is not difficult, 
then, to imagine a gender difference in the relative number of luminance vs. color-
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opponent cells in visual cortex.   Although no such evidence exists in the current 
literature, a possible explanation for the robust gender findings of the present study might 
be that there is a gender dimorphic balance of luminance and chromatic processing in 
visual cortex.   
There may be cyclical effects on many brain areas, including primary (V1) and 
secondary (V2) visual cortex similar to those discussed for the retina and thalamus (see 
Smith and Zubieta, 2001).  After all, estrogen can act directly and quickly on nervous cell 
membranes to increase cerebral blood flow, change regional activation patterns, or 
modulate neurotransmitter release or production (reviewed by Markou et al., 2005; Smith 
and Zubieta, 2001).  Due to infrequent sampling, some hormone effects may have been 
missed in the present study.  It is therefore possible that short-term changes in both 
estradiol and progesterone contributed to the robust between-gender findings. 
We know that there are organizational effects of sex hormones on the mammalian 
brain, but it is difficult to make a clear connection with visual processes.  There are few 
human studies comparing the structure and function of visual cortical areas between 
genders.  Luders et al. (2004) found no gender difference in cortical complexity in 
occipital or temporal regions.   However, Levin et al. (1998) found in a study comparing 
male and female visual responses to light stimulation that males actually had significantly 
higher BOLD responses to a red stimulus than females.  The results of Cowan et al. 
(2000) revealed higher BOLD signal changes to red light in females as compared to 
males.  This finding was not significant (p = 0.15), but female signal changes were higher 
at every red light intensity.  BOLD signal changes to blue light were significantly higher 
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for males, and did not saturated as intensity increased while the signal became saturated 
for females at about 12 lux.  Taken together, these studies do not provide an explanation 
for the present results, as they do not firmly establish a male or female advantage.  This 
suggests either that gender differences do not exist in the cortical response to red or blue 
light stimulation or that BOLD signals are highly dependent on methodology and 
individual differences. 
In cortical area V2 there persists an organization for wavelength sensitivity much 
like that of the retina.  However, just as the ability to discriminate between similar hues 
improves from retina to V1, it becomes further improved from V1 to V2 where the ability 
to make local spatial comparisons is present in approximately 1/3 of color coded V2 cells 
(Moutoussis and Zeki, 2002).  I am not aware of studies that would implicate V2 
specifically in the present between-gender or cyclical findings.  
Visual area 4 (V4) lies on the fusiform gyrus at the junction of the temporal and 
occipital lobes.  Zeki (1993) hypothesized that, while color cells in V1 and V2 follow a 
retinotopic organization and are primarily coded for luminance, V4 is organized in a 
chromatic plan.  To test this, Zeki altered the spectral reflectances from a geometrical 
(“Mondrian”) display and found that V1 cells had identical responses to stimuli of 
different colors provided they reflected the same amount of energy.  Conversely, he 
found that V4 cells had identical responses to different stimulus energies provided the 
chromaticity was unchanged.  Later work revealed a visual area, V4α, which is activated 
by viewing color in natural scenes (Bartels and Zeki, 2000).  Activation of this area 
would be minimal with the simple targets used in the present study.   
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I know of no studies indicating gender differences in V4.  However, V4 has been 
implicated as an attention “gate” for visual stimuli (Moran and Desimone, 1985).  If two 
stimuli lie within a V4 receptive field, responses to unattended stimuli are dramatically 
reduced.  Changes in hormone levels across the menstrual cycle have been associated 
with changes in arousal and possibly attention states as measured by two-flash fusion 
thresholds (Kopell et al., 1969; Braier and Asso, 1980).  In both of these studies, critical 
two-flash fusion flicker thresholds were increased during the luteal phase when compared 
to other menstrual cycle phases.  These results, taken together with Moran and Desimone 
(1985), loosely implicate the menstrual cycle with changes in V4 function. 
 
Other central nervous system structures 
Prefrontal cortex is believed to help orchestrate thought in accordance with 
internal goals (Miller and Cohen, 2001).  It is also known that the hippocampus is 
involved in memory (Brodal, 1969).  On proton magnetic resonance spectroscopy (H 
MRS), higher baseline metabolite concentrations have been observed in the prefrontal 
cortex of females compared to males (Grachev and Apkarian, 2000).  An increase in the 
number of rat hippocampal dendritic spines has been demonstrated in the presence of 
estrogen in cycling females (Gould et al., 1990).  However, given the minimal memory 
requirements of the present experiment, it would be difficult to imagine how gender 
dimorphism in prefrontal cortex or estrogen-related changes in hippocampus would affect 
the present findings. 
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OTHER EFFECTS 
Learning effects 
 In an editorial on gender brain differences, Jones (1998) wrote, “In short, our 
brains are what we teach them to be given their genetically defined templates.”  It is 
possible that all learning or improvement in ability represents neural plasticity (reviewed 
by Tsodyks and Gilbert, 2004).  It is also possible that overall gender differences in life 
experiences may cause a difference in visual system organization.  Munroe and Munroe 
(1971) explored this idea in a study of the male advantage in spatial orientation in a 
primitive culture.  They found that boys tended to be better at orienting themselves to 
their environment without instruction.  However, they also found large within-male 
differences and that boys who had greater spatial abilities were more apt to wander far 
from home. 
Parke and Sawin (1976) found that variations in fathers’ behavior were related to 
their male infants’ behavior.  The suggestion was that there was an environmental 
influence of same sex parenting on child behaviors.  Greene and Gynther (1995) 
suggested that gender differences in color perception “may be a function of differential 
socialization for women and men.”   Since they found perceptual differences (women 
identified significantly more colors than men) and not cognitive differences (no 
differences in vocabulary), they were basically suggesting that environmental influence 
could feedback on to a child’s perception.  It is possible then, that the large between-
gender findings of the present study are in part due to differences in chromatic 
“experiences” afforded boys and girls by caregivers. 
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Mood 
 It has been argued that many women have fluctuations in mood, affect, body 
systems and behavior that occur across the menstrual cycle (Moos et al., 1969).  It could 
be further argued that a portion of the present results is attributable to reduced task 
performance at certain menstrual cycle phases.  However, Guttridge (1996) found that 
mood was not a covariate of standard achromatic visual field performance, and Slade and 
Jenner (1980) found that poor performance on a perception task only correlated with 
mood when the task was very difficult.  Since the tasks involved were very 
straightforward, mood effects do not seem to apply to the present findings. 
 
EXTENSIONS TO FURTHER STUDIES 
 There was a large effect of gender in the present study on the sensitivity to 
chromatic contribution to brightness.  This result combined with the limited effects of 
hormones and the menstrual cycle hint at an innate or genetic mechanism for the gender 
difference.  This would be in agreement with the findings of Iijima et al. (2001).  They 
found that the free drawings of girls affected with congenital adrenal hyperplasia (CAH) 
were more like the drawings of boys than unaffected girls.  A reasonable follow-on to the 
present study could be to compare boys with girls affected and unaffected by CAH.  The 
present study could also be repeated in girls exposed prenatally to higher levels of 
androgens by the presence of a twin brother or exogenous androgenic substances. 
 
 
Foutch, Brian, 2007, UMSL, p. 104 
PHILOSOPHY OF FINDINGS 
 Oen et al. (1994) concluded, “Sex is an important cofactor of contrast sensitivity 
functions that should be controlled for in future studies.”  In spite of this and a myriad of 
results suggesting gender differences in visual function, there seems to be reluctance to 
accept them as real or incorporate gender norms into research protocols or clinical 
practice.  A decade ago, an anonymous editorial in The American Journal of Psychiatry 
(N.C.A., 1997) called for “unbiased opinions” and “careful science” in the design and 
interpretation of studies involving gender as a predictor of behavior or function.  I agree 
but would call for unbiased, careful science in all areas of research. 
 Using a systematic and rigorous approach, I have concluded that females have a 
profound advantage in chromatic contribution to brightness.  This does not mean that 
females necessarily see more color, or that they can discriminate better between colors.  It 
is more related to the findings reviewed by Alexander (2003), suggesting that the relative 
contributions of parvocellular processes are greater in females than males.  I am 
admittedly disappointed by the limited findings of hormone and menstrual cycle effects.  
I do remain convinced that more careful sampling of hormone levels would reveal more 
within-female differences with potential applications to both vision and clinical science. 
 
APPLICATIONS TO VISION SCIENCE AND CLINICAL PRACTICE 
Gender norms for vision science and clinical practice would not be 
straightforward to develop, as there is evidence in the present study that some of the 
gender differences would be modified by sex hormone levels or contraceptive use.  
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Individual differences in menstrual cycle profiles would make modeling gender norms 
even more difficult; however there are a few straightforward recommendations.   
Males and females need to be analyzed separately whenever possible in all color 
research.  There is too much evidence in the present study that females and males differ 
in chromatic processing.  It is also possible that the limited nature of the menstrual cycle 
effects was due to small sample sizes.  With this in mind, careful tracking of the 
menstrual cycle and contraceptive use for large samples might elucidate the effects of 
female sex hormones on chromatic processing.  When these effects are better understood, 
it should be a priority to make the models available for clinical use.   
 
CONCLUSIONS 
1. Females have higher chromatic contribution to brightness than males.  The findings 
supporting this conclusion were robust; however, establishing the exact mechanisms 
responsible for the effect of gender was well beyond the scope of this study. 
2. Hormone level and menstrual cycle phase had limited effects on chromatic 
contribution to brightness across tested wavelengths.  Significant findings at 650 nm 
may result from physiological changes (body temperature, ionic environment and 
blood flow) and agree with previous findings on S-cone mechanisms. 
3. These findings are relevant to both vision research and clinical practice.  Developing 
tools to further model gender and hormonal effects on chromatic processing relies on 
collecting large sample data and should be a priority for the vision science 
community. 
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